RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | lymphoma |
|
Accession: | DOID:0060058
|
browse the term
|
Definition: | A hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs. (DO) |
Synonyms: | exact_synonym: | Germinoblastic Sarcoma; Germinoblastoma; germinoblastic sarcomas; germinoblastomas; lymphoid cancer; lymphomas; malignant lymphoma; malignant lymphomas; reticulolymphosarcoma; reticulolymphosarcomas |
| narrow_synonym: | lymphoma, somatic |
| primary_id: | MESH:D008223 |
| xref: | EFO:0000574; ICD10CM:C85.9; NCI:C128121; NCI:C134786; NCI:C21602; NCI:C3208; NCI:C60448; NCI:C7065 |
|
|
|
G |
Atm |
ataxia telangiectasia mutated |
|
ISO |
DNA:deletion:exon: |
RGD |
PMID:27895165 PMID:28007901 |
RGD:12879393, RGD:12879399 |
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Bcl11b |
B cell leukemia/lymphoma 11B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17941976 |
|
NCBI chr12:107,876,662...107,970,404
Ensembl chr12:107,876,662...107,969,861
|
|
G |
Ccnb1 |
cyclin B1 |
|
IMP |
|
RGD |
PMID:19666607 |
RGD:2315935 |
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Cd274 |
CD274 antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28736328 |
|
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9488045 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9488045 |
|
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
|
ISO |
DNA:missense mutation:CDS p.D140E (rs7479004) (human) |
RGD |
PMID:25407497 |
RGD:153323305 |
NCBI chr 6:125,073,144...125,107,554
Ensembl chr 6:125,072,944...125,107,554
|
|
G |
Ephx1 |
epoxide hydrolase 1, microsomal |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11406608 |
|
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
|
|
G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
susceptibility |
IMP |
|
RGD |
PMID:11238917 |
RGD:11567233 |
NCBI chr14:32,235,248...32,302,947
Ensembl chr14:32,235,478...32,302,947
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
ClinVar Annotator: match by term: Lymphoma |
ClinVar |
PMID:23023262 PMID:24563539 PMID:26619011 |
|
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
ISO |
ClinVar Annotator: match by term: Lymphoma |
ClinVar |
|
|
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11980663 |
|
NCBI chr11:11,634,970...11,722,930
Ensembl chr11:11,634,980...11,722,926
|
|
G |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
|
ISO |
ClinVar Annotator: match by term: Lymphoma |
ClinVar |
|
|
NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085
|
|
G |
Kras |
Kirsten rat sarcoma viral oncogene homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9205081 |
|
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
|
|
G |
Mad1l1 |
MAD1 mitotic arrest deficient 1-like 1 |
|
ISO |
|
RGD |
PMID:11423979 |
RGD:1599865 |
NCBI chr 5:139,994,444...140,307,346
Ensembl chr 5:139,994,444...140,307,307
|
|
G |
Malt1 |
MALT1 paracaspase |
|
ISO |
|
RGD |
PMID:10523859 |
RGD:1599913 |
NCBI chr18:65,564,010...65,611,959
Ensembl chr18:65,564,009...65,612,138
|
|
G |
Mir143 |
microRNA 143 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28736328 |
|
NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
|
|
G |
Mlh1 |
mutL homolog 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15700306 |
|
NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799656 |
|
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799656 |
|
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
|
ISO |
ClinVar Annotator: match by term: Lymphoma |
ClinVar |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:26619011 PMID:28492532 More...
|
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Notch1 |
notch 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18798262 |
|
NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
|
|
G |
Nras |
neuroblastoma ras oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9205081 |
|
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
|
|
G |
Nsd2 |
nuclear receptor binding SET domain protein 2 |
|
ISO |
ClinVar Annotator: match by term: Lymphoma |
ClinVar |
PMID:25741868 |
|
NCBI chr 5:33,974,286...34,055,310
Ensembl chr 5:33,978,069...34,055,319
|
|
G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17441966 |
|
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
|
|
G |
Pafah1b2 |
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 |
|
ISO |
DNA:translocation:intron:t(ll;14)(q23;q32) (human) |
RGD |
PMID:11983068 |
RGD:4107059 |
NCBI chr 9:45,876,609...45,923,988
Ensembl chr 9:45,874,157...45,923,988
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22800774 |
|
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
|
|
G |
Ppp1r9b |
protein phosphatase 1, regulatory subunit 9B |
susceptibility |
IMP |
|
RGD |
PMID:21670604 |
RGD:10043812 |
NCBI chr11:94,882,038...94,897,724
Ensembl chr11:94,881,861...94,897,725
|
|
G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
|
ISO |
|
RGD |
PMID:17609424 |
RGD:6483350 |
NCBI chr17:34,401,006...34,406,347
Ensembl chr17:34,400,961...34,406,738
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22287727 |
|
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
|
|
G |
Ptger4 |
prostaglandin E receptor 4 (subtype EP4) |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19075289 |
|
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
ClinVar Annotator: match by term: Lymphoma |
ClinVar |
PMID:11704759 PMID:11992261 PMID:12161469 PMID:12325025 PMID:12634870 PMID:12960218 PMID:14644997 PMID:15001945 PMID:15928039 PMID:16498234 PMID:17497712 PMID:19077116 PMID:20301303 PMID:21407260 PMID:21533187 PMID:22420426 PMID:22465605 PMID:22711529 PMID:23624134 PMID:23771920 PMID:24033266 PMID:24037001 PMID:24219368 PMID:24451042 PMID:24458522 PMID:24803665 PMID:24935154 PMID:25156961 PMID:25337068 PMID:25741868 PMID:25741869 PMID:25862627 PMID:26084119 PMID:26242988 PMID:26456833 PMID:26467025 PMID:26495027 PMID:26607044 PMID:26817465 PMID:27038324 PMID:27104176 PMID:28492532 PMID:29493581 PMID:29907801 PMID:30055033 PMID:30311386 PMID:30417923 PMID:30692697 PMID:31219622 PMID:31560489 PMID:32164556 PMID:32371413 PMID:32901917 PMID:34008892 More...
|
|
NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460
|
|
G |
Rac2 |
Rac family small GTPase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19783987 |
|
NCBI chr15:78,443,369...78,456,983
Ensembl chr15:78,443,367...78,456,983
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
ISO |
|
RGD |
PMID:9047386 |
RGD:2298891 |
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rpl11 |
ribosomal protein L11 |
susceptibility |
IMP |
|
RGD |
PMID:26489471 |
RGD:11535971 |
NCBI chr 4:135,776,665...135,780,704
Ensembl chr 4:135,755,576...135,780,739
|
|
G |
Setbp1 |
SET binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: Lymphoma |
ClinVar |
|
|
NCBI chr18:78,793,593...79,153,659
Ensembl chr18:78,793,595...79,152,606
|
|
G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
IDA |
|
RGD |
PMID:15231650 |
RGD:1581305 |
NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
|
|
G |
Trp53 |
transformation related protein 53 |
|
EXP ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lymphoma |
CTD ClinVar |
PMID:1565143 PMID:1683921 PMID:1978757 PMID:7887414 PMID:8023157 PMID:8062826 PMID:8118819 PMID:9242456 PMID:9546439 PMID:9569050 PMID:10411893 PMID:10797439 PMID:11139324 PMID:11180592 PMID:11479205 PMID:11782540 PMID:12826609 PMID:15004724 PMID:15381368 PMID:15722483 PMID:16489069 PMID:16682957 PMID:16818505 PMID:17606709 PMID:18511570 PMID:19258306 PMID:19556618 PMID:20113312 PMID:20128691 PMID:20407015 PMID:21187651 PMID:21305319 PMID:21343334 PMID:21445056 PMID:21519010 PMID:21552135 PMID:21601526 PMID:21761402 PMID:22110706 PMID:22186996 PMID:22915647 PMID:23161690 PMID:23246812 PMID:23538418 PMID:24381225 PMID:24487413 PMID:24501221 PMID:24641375 PMID:24651012 PMID:24810334 PMID:25157968 PMID:25741868 PMID:25952993 PMID:26230955 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26822237 PMID:26845104 PMID:27276561 PMID:27463065 PMID:27680515 PMID:27683180 PMID:27895058 PMID:27959731 PMID:28152038 PMID:28369373 PMID:28492532 PMID:29478780 PMID:29489754 PMID:29979965 PMID:30076369 PMID:30224644 PMID:30327374 PMID:30816478 PMID:31105275 PMID:31775759 PMID:32000721 PMID:33372952 PMID:36988593 More...
|
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Twf1 |
twinfilin actin binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19783987 |
|
NCBI chr15:94,475,829...94,487,727
Ensembl chr15:94,475,832...94,487,770
|
|
|
G |
Dot1l |
DOT1 like histone lysine methyltransferase |
treatment |
ISO |
|
RGD |
PMID:23801631 |
RGD:9588291 |
NCBI chr10:80,590,935...80,631,295
Ensembl chr10:80,591,040...80,631,295
|
|
G |
Rnf20 |
ring finger protein 20 |
disease_progression |
IMP |
|
RGD |
PMID:23412334 |
RGD:9831405 |
NCBI chr 4:49,632,005...49,656,887
Ensembl chr 4:49,632,006...49,656,887
|
|
|
G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
ISO |
ClinVar Annotator: match by term: Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified |
ClinVar |
PMID:7585650 PMID:8571952 PMID:9195225 PMID:9238033 PMID:15982307 PMID:22234153 PMID:23221806 PMID:23232694 PMID:24728327 PMID:25716912 PMID:25741868 PMID:26884178 PMID:27504877 PMID:28492532 PMID:29607586 More...
|
|
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
susceptibility |
ISO |
DNA:snps, haplotype:multiple (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22674224 PMID:22674224 |
RGD:8657089 |
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
treatment |
ISO |
DNA:SNP:5'UTR:rs717620(human) DNA:SNPs: :rs717620(human) |
RGD |
PMID:24404132 PMID:25007187 |
RGD:11080959, RGD:11080979 |
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
disease_progression |
ISO |
mRNA:increased expression:mononuclear cell: |
RGD |
PMID:15521915 PMID:12100141 |
RGD:11081076, RGD:11081143 |
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11984797 PMID:21898527 |
|
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
|
|
G |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
ISO |
|
RGD |
PMID:17065136 |
RGD:11100012 |
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
|
|
G |
Aicda |
activation-induced cytidine deaminase |
treatment |
ISO |
|
RGD |
PMID:19759560 |
RGD:11039451 |
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19684603 PMID:19684604 |
|
NCBI chr10:67,928,353...68,114,596
Ensembl chr10:67,928,350...68,114,570
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
|
|
G |
Bax |
BCL2-associated X protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
severity |
ISO |
mRNA:increased expression:bone marrow (human) |
RGD |
PMID:25982455 |
RGD:11076595 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
treatment |
ISO |
mRNA:increased expression:blood, mononuclear cell (human) |
RGD |
PMID:12469194 PMID:19020783 |
RGD:11353852, RGD:11353866 |
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chr10:74,896,384...75,020,755
Ensembl chr10:74,896,424...75,020,753
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22010212 |
|
NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Cast |
calpastatin |
|
ISO |
protein:increased expresssion:B cell |
RGD |
PMID:11264179 |
RGD:5509822 |
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
mRNA:increased expression:bone marrow (human) |
RGD |
PMID:22391157 |
RGD:11352824 |
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cd40lg |
CD40 ligand |
|
IMP |
|
RGD |
PMID:9292526 |
RGD:11352271 |
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd46 |
CD46 antigen, complement regulatory protein |
|
ISO |
protein:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:16353080 |
RGD:11352810 |
NCBI chr 1:194,721,279...194,781,149
Ensembl chr 1:194,719,134...194,774,557
|
|
G |
Cd79b |
CD79B antigen |
|
ISO |
protein:decreased expression:bone marrow, mononuclear cell (human) |
RGD |
PMID:21487112 |
RGD:11250414 |
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Cd86 |
CD86 antigen |
severity |
ISO |
protein:increased expression:peripheral blood, bone marrow, mononuclear cell (human) |
RGD |
PMID:24283754 |
RGD:11354967 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Cdk6 |
cyclin dependent kinase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24736461 |
|
NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
disease_progression no_association susceptibility |
ISO |
DNA:deletion: : DNA:missense mutations:cds: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20453839 PMID:10090949 PMID:9204978 PMID:25675863 PMID:26104880 |
RGD:11251764, RGD:11252081, RGD:11252082, RGD:11057958 |
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19684604 |
|
NCBI chr14:54,947,823...54,949,604
Ensembl chr14:54,947,817...54,949,631
|
|
G |
Cfb |
complement factor B |
|
ISO |
DNA:missense mutation:p.R32Q b(human) |
RGD |
PMID:6958349 |
RGD:11041155 |
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
|
|
G |
Crebbp |
CREB binding protein |
disease_progression |
ISO |
DNA:mutations:multiple |
RGD |
PMID:25917266 |
RGD:11060149 |
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
|
|
G |
Crlf2 |
cytokine receptor-like factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19838194 |
|
NCBI chr 5:109,702,575...109,707,301
Ensembl chr 5:109,702,575...109,706,859
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
treatment |
ISO |
|
RGD |
PMID:9250830 |
RGD:11039038 |
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
severity |
ISO |
|
RGD |
PMID:8562939 |
RGD:734840 |
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
|
|
G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell: |
RGD |
PMID:19222940 |
RGD:11040545 |
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
susceptibility no_association |
ISO |
DNA:polymorphism:3"UTR:rs4646903(human) DNA:polymorphism:cds:2452C>A(p.T461N)(human) DNA:polymorphism:3'UTR:3801T>C(human) |
RGD |
PMID:22964275 PMID:23725389 PMID:16676594 |
RGD:11352714, RGD:11352725, RGD:11352728 |
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
susceptibility |
ISO |
DNA:polymorphisms: : DNA:SNP,deletion:splice junction,exon:1934G>A(human) |
RGD |
PMID:11037802 PMID:19593802 |
RGD:11352820, RGD:11252111 |
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11774269 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
susceptibility disease_progression |
ISO |
DNA:polymorphism: : |
RGD |
PMID:19650988 PMID:22215203 |
RGD:11353796 RGD:11353805 |
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
disease_progression susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:19650988 PMID:22215203 |
RGD:11353796, RGD:11353805 |
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
|
|
G |
Dhfr |
dihydrofolate reductase |
disease_progression |
ISO |
DNA:polymorphisms, haplotype:promoter: DNA:polymorphisms: :-317A>G, 829C>T (human) |
RGD |
PMID:19861437 PMID:9226157 PMID:22969948 PMID:12972803 |
RGD:11039542, RGD:11039543, RGD:11039544, RGD:11039545 |
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
|
|
G |
Dnmt3a |
DNA methyltransferase 3A |
treatment |
ISO |
DNA:mutations:exon, intron:p.R882(human) |
RGD |
PMID:25242092 |
RGD:11041125 |
NCBI chr12:3,851,559...3,964,443
Ensembl chr12:3,856,007...3,964,443
|
|
G |
Dntt |
deoxynucleotidyltransferase, terminal |
|
ISO |
protein:increased activity:peripheral blood,bone marrow: |
RGD |
PMID:7020399 |
RGD:8694149 |
NCBI chr19:41,017,701...41,047,964
Ensembl chr19:41,017,714...41,047,964
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
no_association disease_progression |
ISO |
DNA:SNP: :85T>C (human) DNA:SNPs: :2194G>A, 1156G>T (human) DNA:splice-site mutation:intron:IVS14+1G>A (human) |
RGD |
PMID:26846104 PMID:26846104 PMID:26846104 |
RGD:11098453, RGD:11098453, RGD:11098453 |
NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
|
|
G |
Duxbl1 |
double homeobox B-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27776115 |
|
NCBI chr14:25,979,011...25,990,590
Ensembl chr14:25,979,001...25,990,512
|
|
G |
Ehmt1 |
euchromatic histone methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32889036 |
|
NCBI chr 2:24,680,781...24,809,658
Ensembl chr 2:24,679,940...24,809,626
|
|
G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32889036 |
|
NCBI chr17:35,117,427...35,133,049
Ensembl chr17:35,117,445...35,133,028
|
|
G |
Eng |
endoglin |
disease_progression |
ISO |
|
RGD |
PMID:17572488 |
RGD:11041565 |
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
|
|
G |
Ephx1 |
epoxide hydrolase 1, microsomal |
susceptibility no_association |
ISO |
DNA:missense mutation, haplotype:exon:p.Y113H (human) DNA:missense mutation, haplotype:exon:p.H139R (human) DNA:polymorphisms:exon DNA:SNPs:exon:rs1051740, rs2234922 (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21983886 PMID:21983886 PMID:21983886 PMID:19593802 PMID:22930568 PMID:22200898 More...
|
RGD:11252110, RGD:11252110, RGD:11252111, RGD:11252113, RGD:11252114 |
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
|
|
G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
susceptibility |
ISO |
DNA:SNPs: :8092C>A, 19007G>A (human) DNA:SNPs, haplotypes: :p.R194W, p.R280H, p.R399Q (human) |
RGD |
PMID:16723154 PMID:16435384 |
RGD:11252160, RGD:11340204 |
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
|
|
G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
no_association |
ISO |
DNA:missense mutations: :p.D312N, p.K751Q (human) DNA:haplotype |
RGD |
PMID:19101034 PMID:21987080 |
RGD:11252192, RGD:11340201 |
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
|
|
G |
Erg |
ETS transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27776115 |
|
NCBI chr16:95,160,028...95,387,452
Ensembl chr16:95,160,028...95,387,452
|
|
G |
Etv6 |
ets variant 6 |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:17255265 |
|
NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
IAGP |
OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 |
MouseDO |
|
|
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
F3 |
coagulation factor III |
|
ISO |
|
RGD |
PMID:8429686 |
RGD:11340211 |
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
|
|
G |
Fas |
Fas cell surface death receptor |
disease_progression |
ISO |
protein:increased expression:CD34+ bone marrow cell |
RGD |
PMID:10500800 PMID:9711907 |
RGD:11049148, RGD:11049157 |
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:25317080 |
RGD:11040558 |
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
|
|
G |
Flt3 |
FMS-like tyrosine kinase 3 |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:11290608 PMID:11442493 PMID:14604974 PMID:14670924 PMID:15256420 PMID:16857985 PMID:17606455 PMID:17889720 PMID:19657110 PMID:20733134 PMID:22368270 PMID:22504183 PMID:22504184 PMID:23261068 PMID:23321257 PMID:23430109 PMID:23714533 PMID:23783394 PMID:24046014 PMID:25157968 More...
|
|
NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299
|
|
G |
Fpgs |
folylpolyglutamyl synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25013492 |
|
NCBI chr 2:32,572,621...32,594,208
Ensembl chr 2:32,572,621...32,594,157
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35115686 |
|
NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845
|
|
G |
Gfi1b |
growth factor independent 1B |
|
ISO |
mRNA:increased expression:blood: |
RGD |
PMID:19360458 |
RGD:11040460 |
NCBI chr 2:28,499,462...28,511,994
Ensembl chr 2:28,499,462...28,511,994
|
|
G |
Gh |
growth hormone |
treatment |
ISO |
|
RGD |
PMID:2494952 |
RGD:11352727 |
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
|
|
G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta 1 |
|
ISO |
ClinVar Annotator: match by term: Acute lymphoblastic leukemia | ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Lymphoblastic leukemia CTD Direct Evidence: marker/mechanism |
ClinVar OMIM CTD |
PMID:25485910 PMID:25741868 PMID:27108799 PMID:28492532 PMID:32134617 |
|
NCBI chr 4:155,575,757...155,643,726
Ensembl chr 4:155,575,818...155,643,726
|
|
G |
Gpi1 |
glucose-6-phosphate isomerase 1 |
|
ISO |
|
RGD |
PMID:6589021 |
RGD:11051848 |
NCBI chr 7:33,900,752...33,929,761
Ensembl chr 7:33,900,755...33,929,761
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
ISO |
|
RGD |
PMID:17317918 PMID:24698347 |
RGD:11352774, RGD:11352812 |
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gsr |
glutathione reductase |
|
ISO |
|
RGD |
PMID:24191316 |
RGD:11059506 |
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
disease_progression susceptibility no_association |
ISO |
|
RGD |
PMID:10666194 PMID:15738600 PMID:12827651 PMID:14607752 |
RGD:10450829, RGD:10755321, RGD:10755409, RGD:10755410 |
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
disease_progression no_association susceptibility |
ISO |
DNA:haplotype:cds: DNA:polymorphism: :1578 a>G(human) DNA:transition mutation:exon: |
RGD |
PMID:10666194 PMID:23979883 PMID:15738600 |
RGD:10450829, RGD:10755417, RGD:10755321 |
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
disease_progression susceptibility |
ISO |
|
RGD |
PMID:10666194 PMID:14607752 |
RGD:10450829, RGD:10755410 |
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
susceptibility |
ISO |
DNA:SNP, haplotype:enhancer: (rs807212) (human) |
RGD |
PMID:19806355 |
RGD:10755490 |
NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350
|
|
G |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
|
ISO |
DNA:polymorphisms, haplotype:cds:HLA-DQA1*01 (human) |
RGD |
PMID:9744491 |
RGD:11041762 |
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
|
|
G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
ISO |
DNA:polymorphisms, haplotypes:cds:multiple DNA:polymorphisms, haplotype:cds:HLA-DQB1*0501 (human) |
RGD |
PMID:22434102 PMID:9744491 |
RGD:11041749, RGD:11041762 |
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
|
|
G |
Hck |
hemopoietic cell kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17344919 |
|
NCBI chr 2:152,950,388...152,993,361
Ensembl chr 2:152,950,388...152,993,361
|
|
G |
Hdac1 |
histone deacetylase 1 |
disease_progression |
ISO |
mRNA:increased expression:bone marrow,blood: |
RGD |
PMID:23948281 |
RGD:9681454 |
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
|
|
G |
Hdac2 |
histone deacetylase 2 |
disease_progression |
ISO |
mRNA:increased expression:bone marrow,blood: |
RGD |
PMID:23948281 |
RGD:9681454 |
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
|
|
G |
Hdac4 |
histone deacetylase 4 |
treatment |
ISO |
|
RGD |
PMID:23948281 |
RGD:9681454 |
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
|
|
G |
Hfe |
homeostatic iron regulator |
no_association |
ISO |
DNA:missense mutation:cds:p.H63D (human) DNA:missense mutation:cds:p.C282Y (human) DNA:missense mutation: :p.H63D (human) |
RGD |
PMID:10627122 PMID:10627122 PMID:17107905 |
RGD:10755557, RGD:10755557, RGD:10755558 |
NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
|
|
G |
Hk1 |
hexokinase 1 |
|
ISO |
protein:decreased activity:platelet |
RGD |
PMID:21921332 |
RGD:11353881 |
NCBI chr10:62,104,634...62,215,699
Ensembl chr10:62,104,634...62,215,687
|
|
G |
Hlf |
hepatic leukemia factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26214592 |
|
NCBI chr11:90,227,361...90,281,745
Ensembl chr11:90,227,362...90,281,721
|
|
G |
Hoxd4 |
homeobox D4 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15776434 |
|
NCBI chr 2:74,552,322...74,559,504
Ensembl chr 2:74,542,273...74,559,504
|
|
G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22674224 |
|
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
|
|
G |
Ifng |
interferon gamma |
susceptibility |
ISO |
DNA:SNP: :rs2069727(human) |
RGD |
PMID:21067287 |
RGD:10755691 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Acute lymphocytic leukemia | ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Leukemia, acute lymphocytic, susceptibility to, 2 DNA:SNPs: (human) |
CTD ClinVar RGD |
PMID:19684604 PMID:25741868 PMID:28492532 PMID:24786325 |
RGD:151347631 |
NCBI chr11:11,634,970...11,722,930
Ensembl chr11:11,634,980...11,722,926
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chr 1:69,570,382...69,726,510
Ensembl chr 1:69,570,373...69,726,404
|
|
G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chr11:98,355,436...98,437,157
Ensembl chr11:98,355,728...98,436,857
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
protein:decreased expression:blood |
RGD |
PMID:21653647 PMID:15860861 |
RGD:11049158, RGD:11049169 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
DNA:SNP:intron:rs12203592 (human) |
RGD |
PMID:19897031 |
RGD:11526162 |
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Itpa |
inosine triphosphatase (nucleoside triphosphate pyrophosphatase) |
treatment no_association |
ISO |
DNA:SNPs:exon:94C>A, 138G>A (human) DNA:SNP:intron |
RGD |
PMID:22009189 PMID:22009189 |
RGD:10766474, RGD:10766474 |
NCBI chr 2:130,506,702...130,523,534
Ensembl chr 2:130,509,530...130,523,534
|
|
G |
Kdm2b |
lysine (K)-specific demethylase 2B |
|
ISO |
mRNA:increased expression:bone marrow (human) |
RGD |
PMID:21310926 |
RGD:9588255 |
NCBI chr 5:123,008,727...123,127,333
Ensembl chr 5:123,008,728...123,127,886
|
|
G |
Kdm3b |
KDM3B lysine (K)-specific demethylase 3B |
|
ISO |
protein:increased expression:bone marrow, mononuclear cell (human) |
RGD |
PMID:22615488 |
RGD:9586728 |
NCBI chr18:34,910,061...34,972,423
Ensembl chr18:34,910,100...34,971,713
|
|
G |
Kdm6a |
lysine (K)-specific demethylase 6A |
severity |
ISO |
DNA:mutations:cds:multiple (human) |
RGD |
PMID:22377896 |
RGD:9684944 |
NCBI chr X:18,027,101...18,147,061
Ensembl chr X:18,028,814...18,146,175
|
|
G |
Kmt2a |
lysine (K)-specific methyltransferase 2A |
|
IAGP ISO |
OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 CTD Direct Evidence: marker/mechanism |
MouseDO CTD |
PMID:24736461 PMID:25730765 |
|
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
|
|
G |
Kras |
Kirsten rat sarcoma viral oncogene homolog |
disease_progression |
ISO |
|
RGD |
PMID:17910045 PMID:25917266 |
RGD:11060148, RGD:11060149 |
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
|
|
G |
Mefv |
Mediterranean fever |
susceptibility |
ISO |
DNA:polymorphisms:cds:p.E148Q,M680I(human) |
RGD |
PMID:22942567 |
RGD:11531121 |
NCBI chr16:3,524,838...3,536,073
Ensembl chr16:3,525,082...3,535,961
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
disease_progression treatment |
ISO |
DNA:missense mutation:cds:677C>T (p.A222V) (rs1801133) (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:677C>T (human) |
CTD RGD |
PMID:16706930 PMID:19923983 PMID:21644011 |
RGD:10449398, RGD:10449407 |
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
disease_progression susceptibility no_association |
ISO |
DNA:SNP::rs10925235(human) DNA:polymorphism: :66A>G(human) DNA:polymorphism: :2756A>G(human) |
RGD |
PMID:26605150 PMID:21618417 PMID:15159311 PMID:22453148 |
RGD:11531136, RGD:11531141, RGD:11531140, RGD:11531137 |
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
|
|
G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
susceptibility |
ISO |
DNA:haplotype:cds: CTD Direct Evidence: marker/mechanism DNA:SNP: :rs3776455(human) |
CTD RGD |
PMID:17136115 PMID:17136115 PMID:23940529 |
RGD:11531133, RGD:11531135 |
NCBI chr13:68,708,897...68,730,273
Ensembl chr13:68,708,899...68,730,268
|
|
G |
Myc |
myelocytomatosis oncogene |
disease_progression |
ISO |
|
RGD |
PMID:25784651 |
RGD:11532748 |
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
susceptibility no_association |
ISO |
DNA:polymorphisms: : DNA:polymorphisms,haplotype: : CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22200898 PMID:25804798 PMID:21888617 PMID:22215203 |
RGD:11532767, RGD:11532769, RGD:11353805 |
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
|
|
G |
Nbn |
nibrin |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to |
OMIM CTD ClinVar |
PMID:9590180 PMID:11325820 PMID:12353271 PMID:14559852 PMID:15338273 PMID:16415040 PMID:16474176 PMID:16810201 PMID:17001621 PMID:17695489 PMID:17894553 PMID:17899368 PMID:18023021 PMID:18049891 PMID:18280732 PMID:18612309 PMID:18638378 PMID:19393249 PMID:19452044 PMID:19523210 PMID:19584272 PMID:19813148 PMID:19908051 PMID:21212067 PMID:21302341 PMID:21698754 PMID:22131123 PMID:22373003 PMID:22841127 PMID:22864661 PMID:22995991 PMID:23317186 PMID:23555315 PMID:24033266 PMID:24093751 PMID:24113799 PMID:24549055 PMID:24728327 PMID:24830725 PMID:25117502 PMID:25186627 PMID:25318351 PMID:25619955 PMID:25712764 PMID:25741868 PMID:25980754 PMID:26083025 PMID:26315354 PMID:26467025 PMID:26722329 PMID:26787654 PMID:26898890 PMID:27153395 PMID:27616075 PMID:27621404 PMID:27978560 PMID:28076423 PMID:28135145 PMID:28261280 PMID:28376765 PMID:28492532 PMID:28528518 PMID:28591191 PMID:29335925 PMID:29678143 PMID:29785153 PMID:30287823 PMID:30306255 PMID:30441849 PMID:30590007 PMID:30651582 PMID:31159747 PMID:31415627 PMID:32566746 PMID:33471991 PMID:34072463 More...
|
|
NCBI chr 4:15,955,388...15,992,589
Ensembl chr 4:15,957,925...15,992,589
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
susceptibility disease_progression |
ISO |
DNA:SNP: :rs3918186(human) DNA:polymorphism, haplotype:cds,intron:P.E298D,-786T>C(human) |
RGD |
PMID:23922896 PMID:20510681 |
RGD:11533639, RGD:11533646 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
ISO |
DNA:mutation: :609C>T (human) DNA:missense mutations: :p.R139W (465C>T), p.P187S (609C>T) (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11774269 PMID:17332311 PMID:18444911 PMID:11774269 |
RGD:10769347, RGD:10769359 |
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nras |
neuroblastoma ras oncogene |
disease_progression |
ISO |
DNA:missense mutation:cds: |
RGD |
PMID:25204082 |
RGD:11535045 |
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
|
|
G |
Nsd2 |
nuclear receptor binding SET domain protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24076604 |
|
NCBI chr 5:33,974,286...34,055,310
Ensembl chr 5:33,978,069...34,055,319
|
|
G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23377183 |
|
NCBI chr19:46,873,829...47,003,613
Ensembl chr19:46,871,756...47,003,592
|
|
G |
Nup214 |
nucleoporin 214 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD OMIM |
|
|
NCBI chr 2:31,864,446...31,943,204
Ensembl chr 2:31,864,448...31,943,987
|
|
G |
Pag1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chr 3:9,752,539...9,898,744
Ensembl chr 3:9,752,539...9,898,739
|
|
G |
Pax5 |
paired box 5 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Acute lymphoid leukemia | ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to, 3 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:24013638 PMID:24728327 PMID:25741868 PMID:26214592 PMID:28492532 PMID:30643249 PMID:35094443 More...
|
|
NCBI chr 4:44,524,748...44,710,694
Ensembl chr 4:44,524,757...44,710,487
|
|
G |
Pon1 |
paraoxonase 1 |
susceptibility |
ISO |
DNA:missense mutations:cds:p.L55M (rs854560), p.Q192R (rs662) (human) |
RGD |
PMID:22976839 |
RGD:11552580 |
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
|
|
G |
Pramex1 |
PRAME like, X-linked 1 |
severity |
ISO |
mRNA:increased expression:blood (human) |
RGD |
PMID:27275197 |
RGD:11535025 |
NCBI chr X:134,513,662...134,528,437
Ensembl chr X:134,513,751...134,528,454
|
|
G |
Prdm14 |
PR domain containing 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19043588 |
|
NCBI chr 1:13,183,652...13,197,387
Ensembl chr 1:13,183,681...13,197,387
|
|
G |
Pten |
phosphatase and tensin homolog |
|
IAGP |
OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 |
MouseDO |
|
|
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Runx1 |
runt related transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17255265 |
|
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
|
|
G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17255265 |
|
NCBI chr10:76,868,103...76,886,266
Ensembl chr10:76,868,075...76,896,836
|
|
G |
Snrpe |
small nuclear ribonucleoprotein E |
severity |
ISO |
mRNA:decreased expression:bone marrow, blood, mononuclear cell (human) |
RGD |
PMID:23915977 |
RGD:10768836 |
NCBI chr 1:133,531,609...133,538,018
Ensembl chr 1:133,531,609...133,538,029
|
|
G |
Tal1 |
T cell acute lymphocytic leukemia 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chr 4:114,913,623...114,928,952
Ensembl chr 4:114,913,623...114,928,952
|
|
G |
Tal2 |
T cell acute lymphocytic leukemia 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chr 4:53,779,701...53,788,712
Ensembl chr 4:53,779,705...53,788,712
|
|
G |
Tas2r103 |
taste receptor, type 2, member 103 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19838194 |
|
NCBI chr 6:133,013,126...133,014,064
Ensembl chr 6:133,013,126...133,014,064
|
|
G |
Tcf3 |
transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26214592 |
|
NCBI chr10:80,245,375...80,269,814
Ensembl chr10:80,245,348...80,269,481
|
|
G |
Tcn2 |
transcobalamin 2 |
|
ISO |
protein:altered activity:plasma: |
RGD |
PMID:8754152 |
RGD:11059889 |
NCBI chr11:3,867,077...3,882,078
Ensembl chr11:3,867,192...3,882,159
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
DNA:SNPs:promoter, introns:g.1296486C>T, g.12866516A>C, g.1279790G>A (rs2735940, rs2736100, rs10069690) (human) |
RGD |
PMID:23066086 PMID:15621763 |
RGD:11038654, RGD:11038667 |
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
G |
Tm9sf2 |
transmembrane 9 superfamily member 2 |
|
ISO |
mRNA:increased expression:bone marrow, mononuclear cells (human) |
RGD |
PMID:12730115 |
RGD:2317244 |
NCBI chr14:122,342,290...122,397,015
Ensembl chr14:122,344,450...122,397,016
|
|
G |
Tpmt |
thiopurine methyltransferase |
treatment no_association |
ISO |
DNA:SNPs:multiple DNA:SNPs:introns:12356C>T, 16638C>T, 26354G>T (rs4449636, rs2518463, rs2842949) (human) DNA:SNPs:exon:374C>T, 719A>G (rs2842934, rs1142345) (human) DNA:SNPs: :multiple |
RGD |
PMID:17164697 PMID:22009189 PMID:22009189 PMID:24499706 |
RGD:11038720, RGD:10766474, RGD:10766474, RGD:11038723 |
NCBI chr13:47,175,463...47,196,833
Ensembl chr13:47,175,958...47,198,213
|
|
G |
Trp53 |
transformation related protein 53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23334668 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Tyms |
thymidylate synthase |
treatment |
ISO |
DNA:repeats: : rs347430033(human) |
RGD |
PMID:25007187 |
RGD:11080979 |
NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
|
|
G |
Vpreb1a |
V-set pre-B cell surrogate light chain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26214592 |
|
NCBI chr16:16,686,265...16,687,119
Ensembl chr16:16,686,267...16,688,707
|
|
G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
susceptibility no_association |
ISO |
DNA:missense mutation, haplotype: :p.R399Q (human) DNA:missense mutation: :p.R194W (human) DNA:missense mutation: :p.R399Q (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21983886 PMID:21983886 PMID:19101034 PMID:19101034 |
RGD:11252110, RGD:11252192, RGD:11252192 |
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
|
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:10988075 PMID:11423618 PMID:11853795 PMID:11861307 PMID:11964322 PMID:12130516 PMID:12399961 PMID:12623848 PMID:14559829 PMID:14745431 PMID:15194504 PMID:15256422 PMID:15381060 PMID:18615627 PMID:19466505 PMID:19652056 PMID:20367437 PMID:20512393 PMID:20537386 PMID:20697894 PMID:20963643 PMID:21505103 PMID:21562040 PMID:21762985 PMID:21872826 PMID:21895409 PMID:22306673 PMID:22772060 PMID:22870928 PMID:23355941 PMID:23540562 PMID:23676790 PMID:24236021 PMID:24456693 PMID:25157968 PMID:25686603 PMID:25741868 More...
|
|
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
|
|
G |
Crlf2 |
cytokine receptor-like factor 2 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:19907440 PMID:19965641 PMID:20018760 PMID:22368272 |
|
NCBI chr 5:109,702,575...109,707,301
Ensembl chr 5:109,702,575...109,706,859
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
susceptibility |
ISO |
DNA:polymorphism:G15631T |
RGD |
PMID:19144407 |
RGD:6480472 |
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
|
|
G |
Fgfr1 |
fibroblast growth factor receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156 |
|
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
|
|
G |
Il7r |
interleukin 7 receptor |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:22897847 PMID:22955920 |
|
NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262
|
|
G |
Insl6 |
insulin-like 6 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:18805579 PMID:19470474 PMID:20585391 PMID:22368270 PMID:22955920 |
|
NCBI chr19:29,298,754...29,302,718
Ensembl chr19:29,298,744...29,302,756
|
|
G |
Jak1 |
Janus kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:16239216 PMID:19139102 PMID:19470474 PMID:19838194 PMID:20167706 PMID:21436584 PMID:21680795 PMID:22955920 PMID:25356970 PMID:28111307 More...
|
|
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features |
ClinVar |
PMID:18805579 PMID:19470474 PMID:20585391 PMID:22368270 PMID:22955920 |
|
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
ClinVar Annotator: match by term: LYMPHOMATOUS ALL |
ClinVar |
PMID:10982185 PMID:16843266 PMID:18270328 PMID:20132407 PMID:20372971 PMID:21599579 PMID:21821710 PMID:24728327 PMID:25157968 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
|
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16497974 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18688853 |
|
NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 5:140,858,754...140,986,351
Ensembl chr 5:140,858,745...140,986,337
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
|
|
G |
Cd163 |
CD163 antigen |
disease_progression |
ISO |
protein:increased expression:lymph node tumor (human) |
RGD |
PMID:23557330 |
RGD:42721976 |
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
|
|
G |
Cd274 |
CD274 antigen |
disease_progression |
ISO |
|
RGD |
PMID:27418641 |
RGD:41412177 |
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
|
|
G |
Cd28 |
CD28 antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
|
|
G |
Cd68 |
CD68 antigen |
disease_progression |
ISO |
protein:increased expression:lymph node tumor (human) |
RGD |
PMID:23557330 |
RGD:42721976 |
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
|
|
G |
Cd80 |
CD80 antigen |
|
ISO |
|
RGD |
PMID:10590132 |
RGD:6902938 |
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
|
|
G |
Cd86 |
CD86 antigen |
|
ISO |
|
RGD |
PMID:10590132 |
RGD:6902938 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr18:61,687,307...61,723,391
Ensembl chr18:61,688,345...61,723,132
|
|
G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 2:152,068,468...152,123,772
Ensembl chr 2:152,068,759...152,123,772
|
|
G |
Csnk2b |
casein kinase 2, beta polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr17:35,335,171...35,341,029
Ensembl chr17:35,335,172...35,341,029
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
|
|
G |
Fas |
Fas cell surface death receptor |
susceptibility |
ISO |
DNA:polymorphism:promoter: -670 G>A(human) protein:increased expression:peripheral blood mononuclear cell: |
RGD |
PMID:17962369 PMID:7513372 |
RGD:11049147, RGD:11049453 |
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Foxp3 |
forkhead box P3 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23962110 PMID:23797717 |
RGD:38456007 |
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
|
|
G |
Fyn |
Fyn proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845
|
|
G |
Gpr183 |
G protein-coupled receptor 183 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr14:122,189,743...122,202,605
Ensembl chr14:122,189,963...122,202,607
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874
|
|
G |
Icos |
inducible T cell co-stimulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 1:60,999,909...61,039,481
Ensembl chr 1:61,017,086...61,039,479
|
|
G |
Ifna1 |
interferon alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20370541 |
|
NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893
|
|
G |
Ifng |
interferon gamma |
treatment |
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23962110 PMID:8800741 |
RGD:10755707 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 1:69,570,382...69,726,510
Ensembl chr 1:69,570,373...69,726,404
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23962110 PMID:8704212 |
RGD:11049460 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23962110 |
|
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23962110 |
|
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il5 |
interleukin 5 |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:16425276 |
RGD:11354942 |
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:10374863 |
RGD:11060275 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
DNA:missense mutations: :p.L156P, p.R172Q, p.E183G (human) |
RGD |
PMID:21821710 |
RGD:11531131 |
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
|
|
G |
Myb |
myeloblastosis oncogene |
disease_progression |
ISO |
mRNA:splice variants:CD4+ T cell: |
RGD |
PMID:27307595 |
RGD:11532670 |
NCBI chr10:21,000,829...21,036,883
Ensembl chr10:21,000,834...21,036,883
|
|
G |
Notch1 |
notch 1 |
|
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:16707600 |
RGD:1580759 |
NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
|
|
G |
Nras |
neuroblastoma ras oncogene |
disease_progression |
IMP |
|
RGD |
PMID:21586752 |
RGD:11535055 |
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 2:160,573,230...160,617,680
Ensembl chr 2:160,573,220...160,617,680
|
|
G |
Prkcb |
protein kinase C, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24090995 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Tal2 |
T cell acute lymphocytic leukemia 2 |
|
ISO |
|
RGD |
PMID:1763056 |
RGD:1599285 |
NCBI chr 4:53,779,701...53,788,712
Ensembl chr 4:53,779,705...53,788,712
|
|
G |
Terf2 |
telomeric repeat binding factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17643074 |
|
NCBI chr 8:107,796,032...107,823,180
Ensembl chr 8:107,796,032...107,823,179
|
|
G |
Tlx1 |
T cell leukemia, homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1717256 |
|
NCBI chr19:45,138,531...45,145,382
Ensembl chr19:45,139,119...45,145,382
|
|
G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
|
|
G |
Trp53 |
transformation related protein 53 |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Trp73 |
transformation related protein 73 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr 4:154,140,706...154,224,332
Ensembl chr 4:154,140,706...154,224,665
|
|
G |
Vav1 |
vav 1 oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26437031 |
|
NCBI chr17:57,586,080...57,636,236
Ensembl chr17:57,586,100...57,635,031
|
|
|
G |
Alk |
anaplastic lymphoma kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16151469 PMID:19503098 PMID:21345110 PMID:22155737 PMID:22920921 PMID:22968692 PMID:15659732 More...
|
RGD:1600902 |
NCBI chr17:72,174,206...72,911,719
Ensembl chr17:72,175,967...72,911,622
|
|
G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17157164 |
|
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
DNA:translocation |
RGD |
PMID:18987657 |
RGD:11526155 |
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Junb |
jun B proto-oncogene |
|
ISO |
|
RGD |
PMID:12145210 |
RGD:1549449 |
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
|
|
G |
Npm1 |
nucleophosmin 1 |
|
ISO |
|
RGD |
PMID:15659732 |
RGD:1600902 |
NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17261581 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22155737 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Tnfrsf8 |
tumor necrosis factor receptor superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10908157 PMID:17261581 |
|
NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734
|
|
G |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22155737 |
|
NCBI chr12:34,007,670...34,009,830
Ensembl chr12:34,007,670...34,009,828
|
|
|
G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
ISO |
ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia |
ClinVar |
PMID:23623386 PMID:25741868 |
|
NCBI chr16:12,927,230...12,969,873
Ensembl chr16:12,927,548...12,968,481
|
|
G |
LOC107983946 |
Wt1 promoter region |
|
ISO |
ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia |
ClinVar |
PMID:8621495 PMID:12640141 PMID:16987884 PMID:25741868 PMID:28492532 PMID:28811308 More...
|
|
NCBI chr 2:104,956,361...104,957,127
|
|
G |
Nf1 |
neurofibromin 1 |
|
ISO |
ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia |
ClinVar |
PMID:9536098 PMID:17576681 PMID:23656349 PMID:25741868 PMID:28492532 |
|
NCBI chr11:79,223,541...79,472,435
Ensembl chr11:79,230,519...79,472,438
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia |
ClinVar |
PMID:8621495 PMID:12640141 PMID:16987884 PMID:25741868 PMID:28492532 PMID:28811308 More...
|
|
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
susceptibility |
ISO |
DNA:SNPs,haplotype: :rs1481012,rs2231142(human) |
RGD |
PMID:21918980 |
RGD:11080977 |
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Acoxl |
acyl-Coenzyme A oxidase-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chr 2:127,680,717...127,968,172
Ensembl chr 2:127,680,796...127,965,793
|
|
G |
Aicda |
activation-induced cytidine deaminase |
disease_progression |
ISO |
|
RGD |
PMID:21133730 |
RGD:11039455 |
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
|
|
G |
Apoe |
apolipoprotein E |
disease_progression |
ISO |
|
RGD |
PMID:18784741 |
RGD:11040549 |
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
|
|
G |
Atm |
ataxia telangiectasia mutated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17968022 |
|
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Bcl11a |
BCL11 transcription factor A |
|
ISO |
DNA:translocation:5' utr: (human) |
RGD |
PMID:11719382 |
RGD:11100004 |
NCBI chr11:24,026,498...24,123,558
Ensembl chr11:24,028,056...24,124,123
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
treatment severity no_association |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:B cell (human) DNA:snp:promoter:g.-938C>A (human) |
CTD RGD |
PMID:21750559 PMID:23770605 PMID:17296974 PMID:20001236 PMID:17959858 PMID:16960146 More...
|
RGD:11522735, RGD:11526110, RGD:11526105, RGD:11526104 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bmf |
BCL2 modifying factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chr 2:118,359,238...118,385,280
Ensembl chr 2:118,359,238...118,380,168
|
|
G |
Braf |
Braf transforming gene |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12068308 PMID:12198537 PMID:12692057 PMID:12960123 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15035987 PMID:16187918 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17704260 PMID:18039235 PMID:18060073 PMID:18368129 PMID:18413255 PMID:18794803 PMID:19206169 PMID:19376813 PMID:19383316 PMID:19537845 PMID:19913317 PMID:20350999 PMID:20619739 PMID:21062266 PMID:21129611 PMID:21639808 PMID:22048237 PMID:22310681 PMID:22495831 PMID:22663011 PMID:22972589 PMID:23352452 PMID:23680146 PMID:24033266 PMID:24451042 PMID:25155755 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:28832562 PMID:29595366 More...
|
|
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
treatment |
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia |
ClinVar RGD |
PMID:24869598 PMID:25741868 PMID:28492532 PMID:23045577 |
RGD:11040699 |
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
|
|
G |
Cbl |
Casitas B-lineage lymphoma |
severity |
ISO |
mRNA,protein:increased expression:CD5+ B cell: DNA:hypophosphorylation:CD5+ B cell: |
RGD |
PMID:17804547 PMID:17804547 |
RGD:11038803, RGD:11038803 |
NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346
|
|
G |
Ccdc50 |
coiled-coil domain containing 50 |
|
ISO |
|
RGD |
PMID:19641524 |
RGD:9685139 |
NCBI chr16:27,205,815...27,270,968
Ensembl chr16:27,207,619...27,270,968
|
|
G |
Cd40 |
CD40 antigen |
|
ISO |
|
RGD |
PMID:20616215 |
RGD:5490532 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd40lg |
CD40 ligand |
|
IMP |
mouse-human chimeric gene in human |
RGD |
PMID:20882050 |
RGD:11352235 |
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd5 |
CD5 antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chr19:10,695,471...10,716,390
Ensembl chr19:10,694,480...10,716,366
|
|
G |
Cd79b |
CD79B antigen |
|
ISO |
protein:decreased expression:B lymphocyte, cell surface (human) DNA:polymorphism:multiple (human) mRNA, protein:splice variants, alternative forms:exon 3 (human) |
RGD |
PMID:9269755 PMID:10552962 PMID:10090943 |
RGD:11250403, RGD:151665202, RGD:151665190 |
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Cd86 |
CD86 antigen |
severity |
ISO |
protein:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:25179679 |
RGD:11354969 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20062064 |
|
NCBI chr 7:80,996,774...81,105,207
Ensembl chr 7:80,996,774...81,105,213
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
protein:increased expression:T cell |
RGD |
PMID:16094420 PMID:15914560 |
RGD:11344923, RGD:11352246 |
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
|
|
G |
Dkc1 |
dyskeratosis congenita 1, dyskerin |
|
ISO |
|
RGD |
PMID:18077792 |
RGD:11251735 |
NCBI chr X:74,139,460...74,153,382
Ensembl chr X:74,139,460...74,153,383
|
|
G |
Dnmt3b |
DNA methyltransferase 3B |
|
ISO |
mRNA:decreased expression: B cell |
RGD |
PMID:15467427 |
RGD:9589146 |
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
|
|
G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
severity |
ISO |
DNA:SNP: :p.K751Q (rs13181) (human) |
RGD |
PMID:22739018 PMID:19484764 |
RGD:11252203, RGD:11252204 |
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
|
|
G |
Farp2 |
FERM, RhoGEF and pleckstrin domain protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20062064 |
|
NCBI chr 1:93,439,826...93,549,698
Ensembl chr 1:93,439,801...93,549,698
|
|
G |
Fas |
Fas cell surface death receptor |
disease_progression |
ISO |
|
RGD |
PMID:12901972 |
RGD:11049461 |
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fbxw7 |
F-box and WD-40 domain protein 7 |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:25741868 PMID:26619011 |
|
NCBI chr 3:84,721,901...84,886,505
Ensembl chr 3:84,722,575...84,886,505
|
|
G |
Fcgr4 |
Fc receptor, IgG, low affinity IV |
no_association |
ISO |
DNA:SNP:exon:p.F158V (rs396991) (human) |
RGD |
PMID:14563637 |
RGD:11352260 |
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
|
|
G |
Gnas |
GNAS complex locus |
disease_progression |
ISO |
DNA:polymorphism:393T>C (human) |
RGD |
PMID:17020971 |
RGD:1601379 |
NCBI chr 2:174,126,113...174,188,537
Ensembl chr 2:174,126,113...174,188,537
|
|
G |
Hras |
Harvey rat sarcoma virus oncogene |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:31775759 PMID:32732226 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
severity |
ISO |
|
RGD |
PMID:7658704 |
RGD:11354983 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Ifng |
interferon gamma |
susceptibility |
ISO |
DNA:polymorphism: :847A>T(human) |
RGD |
PMID:19757192 |
RGD:10755703 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il10 |
interleukin 10 |
disease_progression no_association |
ISO |
protein:increased expression:serum DNA:SNPs: :multiple DNA:SNPs: :rs1800890, rs4072227, rs17015865 (human) |
RGD |
PMID:22945689 PMID:10638947 PMID:19573080 PMID:19573080 |
RGD:11041895, RGD:11049174, RGD:11049165, RGD:11049165 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:19074885 |
RGD:11051968 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
severity |
ISO |
DNA:SNP:promoter:-511C>T (human) protein:decreased expression:plasma: |
RGD |
PMID:18271063 PMID:10870116 |
RGD:11051967, RGD:11522755 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:decreased expression:plasma: |
RGD |
PMID:10870116 |
RGD:11522755 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:plasma: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18006695 PMID:10870116 |
RGD:11522755 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Irf4 |
interferon regulatory factor 4 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18758461 PMID:12393648 PMID:12079517 |
RGD:11526160, RGD:11530024 |
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Itga4 |
integrin alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21093051 |
|
NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467
|
|
G |
Kras |
Kirsten rat sarcoma viral oncogene homolog |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:2278970 PMID:3122217 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 More...
|
|
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:31775759 PMID:32732226 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 7:140,774,024...140,789,968
Ensembl chr 7:140,774,070...140,789,968
|
|
G |
Mir143 |
microRNA 143 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17892514 |
|
NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
|
|
G |
Mir145a |
microRNA 145a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17892514 |
|
NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
|
|
G |
Ms4a1 |
membrane-spanning 4-domains, subfamily A, member 1 |
|
ISO |
|
RGD |
PMID:19911856 |
RGD:2316994 |
NCBI chr19:11,227,043...11,243,513
Ensembl chr19:11,227,039...11,243,605
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16706930 |
|
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:26619011 PMID:28492532 More...
|
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Nras |
neuroblastoma ras oncogene |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 More...
|
|
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
|
|
G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11003599 |
|
NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495
|
|
G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
severity |
ISO |
protein:increased expression:B cell (human) |
RGD |
PMID:12673718 |
RGD:11541127 |
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
|
|
G |
Plcg2 |
phospholipase C, gamma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia |
CTD ClinVar |
PMID:24869598 PMID:27542411 PMID:28492532 |
|
NCBI chr 8:118,225,014...118,361,881
Ensembl chr 8:118,225,030...118,361,881
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636
|
|
G |
Polb |
polymerase (DNA directed), beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chr 8:23,118,135...23,143,482
Ensembl chr 8:23,118,142...23,143,451
|
|
G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16038780 |
|
NCBI chr12:110,413,532...110,549,509
Ensembl chr12:110,413,554...110,549,496
|
|
G |
Pramex1 |
PRAME like, X-linked 1 |
|
ISO |
protein:increased expression:mononuclear cell (human) |
RGD |
PMID:16620968 |
RGD:11535021 |
NCBI chr X:134,513,662...134,528,437
Ensembl chr X:134,513,751...134,528,454
|
|
G |
Prkd2 |
protein kinase D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18758461 |
|
NCBI chr 7:16,576,827...16,604,386
Ensembl chr 7:16,576,827...16,604,389
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16314473 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:12717436 PMID:14644997 PMID:15385933 PMID:15710330 PMID:15928039 PMID:16358218 PMID:17972951 PMID:19047918 PMID:19179468 PMID:24033266 PMID:25097206 PMID:25395418 PMID:25741868 PMID:26619011 PMID:27069254 PMID:28098151 PMID:30868567 More...
|
|
NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460
|
|
G |
Qpct |
glutaminyl-peptide cyclotransferase (glutaminyl cyclase) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770605 |
|
NCBI chr17:79,359,335...79,397,807
Ensembl chr17:79,359,335...79,397,807
|
|
G |
Rbl2 |
RB transcriptional corepressor like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16038780 |
|
NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
|
|
G |
Sf3b1 |
splicing factor 3b, subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
CTD ClinVar |
PMID:22158541 PMID:23634996 PMID:25741868 PMID:26619011 |
|
NCBI chr 1:55,024,328...55,066,660
Ensembl chr 1:55,024,328...55,066,640
|
|
G |
Sf3b2 |
splicing factor 3b, subunit 2 |
|
ISO |
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:26619011 |
|
NCBI chr19:5,323,949...5,345,485
Ensembl chr19:5,323,960...5,345,483
|
|
G |
Tert |
telomerase reverse transcriptase |
disease_progression |
ISO |
|
RGD |
PMID:17344921 |
RGD:11038662 |
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16904380 |
|
NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:21812019 |
RGD:5685033 |
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
|
|
G |
Tnf |
tumor necrosis factor |
disease_progression |
ISO |
protein:increased expression:bone marrow, blood, lymphocyte |
RGD |
PMID:12010662 PMID:22945689 |
RGD:10449463, RGD:11041895 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
susceptibility |
ISO |
DNA:missense mutation:cds:p.E228A (c.683A>C) (human) DNA:SNP: :1322A>G (human) |
RGD |
PMID:16217763 PMID:15531454 |
RGD:11038717, RGD:11038718 |
NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
|
|
G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16270354 |
|
NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709
|
|
G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16270354 |
|
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
|
|
G |
Tnfsf13 |
tumor necrosis factor (ligand) superfamily, member 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15488762 |
RGD:1549466 |
NCBI chr11:69,573,403...69,576,380
Ensembl chr11:69,573,672...69,576,610
|
|
G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
|
|
G |
Topbp1 |
topoisomerase (DNA) II binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18006695 |
|
NCBI chr 9:103,182,351...103,227,627
Ensembl chr 9:103,182,414...103,227,627
|
|
G |
Trp53 |
transformation related protein 53 |
disease_progression |
ISO |
DNA:deletion: : ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia | ClinVar Annotator: match by term: Leukemia, B-cell, chronic CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:1359493 PMID:1565143 PMID:1565144 PMID:1631137 PMID:1679237 PMID:1683921 PMID:1978757 PMID:2046748 PMID:2531845 PMID:2554494 PMID:7651740 PMID:7732013 PMID:7737263 PMID:7791795 PMID:7887414 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8423216 PMID:8425176 PMID:8479749 PMID:8527048 PMID:8718514 PMID:8825920 PMID:9150393 PMID:9242456 PMID:9290701 PMID:9364015 PMID:9407971 PMID:9546439 PMID:9569050 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9825943 PMID:9839505 PMID:10064694 PMID:10089074 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10589545 PMID:10713666 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10922393 PMID:11051239 PMID:11139324 PMID:11180592 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11593407 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12406399 PMID:12506399 PMID:12672316 PMID:12700230 PMID:12726864 PMID:12826609 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15381368 PMID:15390294 PMID:15607980 PMID:15607981 PMID:15722483 PMID:15825182 PMID:15925506 PMID:15951970 PMID:15977174 PMID:16337994 PMID:16401470 PMID:16439677 PMID:16489069 PMID:16682957 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17540308 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17881637 PMID:18307025 PMID:18511570 PMID:18685109 PMID:18937320 PMID:19101993 PMID:19147582 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19556618 PMID:19681600 PMID:19850740 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20128691 PMID:20308654 PMID:20407015 PMID:20505364 PMID:20516128 PMID:20522432 PMID:20693561 PMID:20805372 PMID:20878954 PMID:21056685 PMID:21059199 PMID:21115975 PMID:21159183 PMID:21187651 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21761402 PMID:22006311 PMID:22110706 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22484423 PMID:22713868 PMID:22811390 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23263379 PMID:23265383 PMID:23484829 PMID:23538418 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24381225 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24744791 PMID:24810334 PMID:25157968 PMID:25293557 PMID:25294809 PMID:25339994 PMID:25503501 PMID:25504633 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:26014290 PMID:26024390 PMID:26230955 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26534844 PMID:26585234 PMID:26619011 PMID:26681312 PMID:26781615 PMID:26787237 PMID:26822237 PMID:26845104 PMID:27179933 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27493922 PMID:27501770 PMID:27523101 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27873457 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28152038 PMID:28160093 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28873162 PMID:29025599 PMID:29300620 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29752822 PMID:29979965 PMID:30076369 PMID:30216591 PMID:30224644 PMID:30322717 PMID:30327374 PMID:30583724 PMID:30630526 PMID:30709875 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31105275 PMID:31119730 PMID:31127191 PMID:31300551 PMID:31494577 PMID:31748977 PMID:31775759 PMID:31882575 PMID:32000721 PMID:32187361 PMID:32295079 PMID:32817165 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33372952 PMID:33471991 PMID:34026625 PMID:34308366 PMID:34994652 PMID:36988593 PMID:10867151 More...
|
RGD:11075074 |
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Vdr |
vitamin D (1,25-dihydroxyvitamin D3) receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12446453 |
|
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
|
|
G |
Xpo1 |
exportin 1 |
|
ISO |
ClinVar Annotator: match by term: Leukemia, B-cell, chronic |
ClinVar |
PMID:26619011 |
|
NCBI chr11:23,205,768...23,248,250
Ensembl chr11:23,206,041...23,248,249
|
|
G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
severity no_association |
ISO |
DNA:SNP: :p.R399Q (rs25487) (human) DNA:SNP: :p.R194W (rs1799782), p.R280H (25489) (human) |
RGD |
PMID:19484764 PMID:19484764 |
RGD:11252204, RGD:11252204 |
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
susceptibility |
ISO |
DNA:SNP: :rs6857600(human) |
RGD |
PMID:21918980 |
RGD:11080977 |
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Aicda |
activation-induced cytidine deaminase |
|
IMP |
|
RGD |
PMID:17251349 |
RGD:11039449 |
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
|
|
G |
Bcl2l2 |
BCL2-like 2 |
disease_progression |
IMP |
|
RGD |
PMID:28094768 |
RGD:14394511 |
NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691 Ensembl chr14:55,120,834...55,125,691
|
|
G |
Bcl6 |
B cell leukemia/lymphoma 6 |
|
ISO |
diffuse large B-cell lymphoma |
RGD |
PMID:11821949 |
RGD:1600111 |
NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
|
|
G |
Brd2 |
bromodomain containing 2 |
|
ISO |
|
RGD |
PMID:14563639 |
RGD:9586345 |
NCBI chr17:34,330,993...34,341,581
Ensembl chr17:34,330,997...34,341,608
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
treatment |
IMP ISO |
human cell in a mouse model |
RGD |
PMID:25662332 PMID:28348046 |
RGD:11040764, RGD:124713554 |
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
|
|
G |
Cbx7 |
chromobox 7 |
|
IMP |
|
RGD |
PMID:17374722 |
RGD:11352707 |
NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320
|
|
G |
Cd40 |
CD40 antigen |
|
ISO |
|
RGD |
PMID:20616215 |
RGD:5490532 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
treatment |
IDA |
|
RGD |
PMID:8469286 |
RGD:10450244 |
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11042651 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Eaf2 |
ELL associated factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20564326 |
|
NCBI chr16:36,613,246...36,695,275
Ensembl chr16:36,613,246...36,695,365
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
severity treatment |
IMP ISO IAGP |
|
MouseDO RGD |
PMID:23982173 PMID:29456795 |
RGD:10755356, RGD:126781726 |
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
diffuse large B-cell lymphoma |
RGD |
PMID:11821949 |
RGD:1600111 |
NCBI chr 7:125,202,424...125,232,742
Ensembl chr 7:125,202,601...125,232,742
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24837469 |
|
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
|
|
G |
Kat5 |
K(lysine) acetyltransferase 5 |
severity |
IMP |
|
RGD |
PMID:17728759 |
RGD:9588481 |
NCBI chr19:5,653,042...5,661,584
Ensembl chr19:5,653,042...5,660,265
|
|
G |
Lgals1 |
lectin, galactose binding, soluble 1 |
|
ISO |
protein:increased expression:primary tumor (rat) |
RGD |
PMID:16733672 |
RGD:2316550 |
NCBI chr15:78,810,925...78,814,665
Ensembl chr15:78,810,925...78,814,665
|
|
G |
Mir143 |
microRNA 143 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17892514 |
|
NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
|
|
G |
Mir145a |
microRNA 145a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17892514 |
|
NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
|
|
G |
Nras |
neuroblastoma ras oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14633661 |
|
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14654083 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24531327 |
|
NCBI chr 2:167,772,670...167,821,305
Ensembl chr 2:167,773,977...167,821,305
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
IMP |
|
RGD |
PMID:27018255 |
RGD:151665817 |
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
|
|
G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
|
|
G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
IDA |
|
RGD |
PMID:10202049 |
RGD:2317349 |
NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
|
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
treatment |
ISO |
|
RGD |
PMID:21481795 |
RGD:11038814 |
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Akr1c18 |
aldo-keto reductase family 1, member C18 |
treatment |
ISO |
|
RGD |
PMID:26116659 |
RGD:11541128 |
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
|
|
G |
Atf7ip |
activating transcription factor 7 interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24413735 |
|
NCBI chr 6:136,495,787...136,587,848
Ensembl chr 6:136,483,165...136,587,860
|
|
G |
Bcl2l1 |
BCL2-like 1 |
severity |
IMP |
|
RGD |
PMID:18216295 |
RGD:11531108 |
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
|
IMP |
BCR/ABL fusion |
RGD |
PMID:9310467 |
RGD:41404633 |
NCBI chr10:74,896,384...75,020,755
Ensembl chr10:74,896,424...75,020,753
|
|
G |
Brd2 |
bromodomain containing 2 |
|
ISO |
|
RGD |
PMID:14563639 |
RGD:9586345 |
NCBI chr17:34,330,993...34,341,581
Ensembl chr17:34,330,997...34,341,608
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24154679 |
|
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
|
|
G |
Ccnd1 |
cyclin D1 |
|
IEP |
mRNA:increased expression:B cell (mouse) |
RGD |
PMID:23169640 |
RGD:11353783 |
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
treatment susceptibility |
IMP ISO |
DNA:mutation:cds:c.442C>T,p.A148T,rs3731249 (human) |
RGD |
PMID:16618932 PMID:26104880 PMID:21622646 |
RGD:11251751, RGD:11057958, RGD:11251772 |
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Crlf2 |
cytokine receptor-like factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24141364 |
|
NCBI chr 5:109,702,575...109,707,301
Ensembl chr 5:109,702,575...109,706,859
|
|
G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
treatment |
ISO |
DNA:polymorphisms: : |
RGD |
PMID:21225912 |
RGD:11353807 |
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
treatment |
ISO |
DNA:polymorphisms: : |
RGD |
PMID:21225912 |
RGD:11353807 |
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
|
|
G |
Duxbl1 |
double homeobox B-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27019113 |
|
NCBI chr14:25,979,011...25,990,590
Ensembl chr14:25,979,001...25,990,512
|
|
G |
Etv6 |
ets variant 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15217836 PMID:24413735 PMID:25807284 |
|
NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
|
|
G |
F13a1 |
coagulation factor XIII, A1 subunit |
|
ISO |
protein:increased expression:B lymphoblast: |
RGD |
PMID:16894461 |
RGD:11041855 |
NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220
|
|
G |
F3 |
coagulation factor III |
treatment |
ISO |
|
RGD |
PMID:19874310 |
RGD:11341694 |
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
|
|
G |
Fh1 |
fumarate hydratase 1 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
|
|
G |
Flt3 |
FMS-like tyrosine kinase 3 |
|
ISO |
mRNA,protein:increased expression:bone marrow: |
RGD |
PMID:8562934 |
RGD:11049466 |
NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24141364 |
|
NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
disease_progression |
ISO |
DNA:mutations: : CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:24141364 PMID:22699455 |
RGD:11075072 |
NCBI chr11:11,634,970...11,722,930
Ensembl chr11:11,634,980...11,722,926
|
|
G |
Il5 |
interleukin 5 |
|
IMP |
|
RGD |
PMID:15368290 |
RGD:7241068 |
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
IMP |
|
RGD |
PMID:25006123 PMID:20585039 PMID:21818355 |
RGD:11526159, RGD:11530030, RGD:11530020 |
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Irf8 |
interferon regulatory factor 8 |
|
IMP |
|
RGD |
PMID:20585039 |
RGD:11530030 |
NCBI chr 8:121,463,097...121,483,433
Ensembl chr 8:121,463,097...121,483,433
|
|
G |
Isx |
intestine specific homeobox |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chr 8:75,599,326...75,620,134
Ensembl chr 8:75,599,801...75,620,134
|
|
G |
Mga |
MAX gene associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24413735 |
|
NCBI chr 2:119,702,974...119,800,610
Ensembl chr 2:119,727,709...119,800,062
|
|
G |
Myb |
myeloblastosis oncogene |
disease_progression |
ISO |
mRNA:splice variants:cds: |
RGD |
PMID:21853052 |
RGD:11532669 |
NCBI chr10:21,000,829...21,036,883
Ensembl chr10:21,000,834...21,036,883
|
|
G |
Myc |
myelocytomatosis oncogene |
|
IMP |
|
RGD |
PMID:22120021 |
RGD:7207416 |
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Pax5 |
paired box 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24013638 PMID:30643249 |
|
NCBI chr 4:44,524,748...44,710,694
Ensembl chr 4:44,524,757...44,710,487
|
|
G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
treatment |
IDA |
|
RGD |
PMID:22447844 |
RGD:11075097 |
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Runx1 |
runt related transcription factor 1 |
onset |
ISO |
DNA:amplification CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15217836 PMID:24413735 PMID:21822204 |
RGD:6482828 |
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19796711 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
protein:increased phosphorylation:bone marrow (human) |
RGD |
PMID:27018255 |
RGD:151665817 |
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:26080840 PMID:26295973 PMID:28492532 |
|
NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516
|
|
G |
Sufu |
SUFU negative regulator of hedgehog signaling |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr19:46,385,335...46,477,243
Ensembl chr19:46,385,335...46,477,243
|
|
G |
Tcf3 |
transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19246562 |
|
NCBI chr10:80,245,375...80,269,814
Ensembl chr10:80,245,348...80,269,481
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35687267 |
|
NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
treatment |
ISO |
|
RGD |
PMID:19874310 |
RGD:11341694 |
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
|
|
G |
Tnfsf13 |
tumor necrosis factor (ligand) superfamily, member 13 |
|
ISO |
|
RGD |
PMID:15488762 |
RGD:1549466 |
NCBI chr11:69,573,403...69,576,380
Ensembl chr11:69,573,672...69,576,610
|
|
G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
|
|
G |
Trp53 |
transformation related protein 53 |
disease_progression |
ISO |
DNA:mutations: : |
RGD |
PMID:22699455 |
RGD:11075072 |
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 |
ClinVar |
PMID:22658618 PMID:25741868 PMID:28492532 |
|
NCBI chr17:88,282,478...88,298,320
Ensembl chr17:88,282,490...88,298,320
|
|
|
G |
Bmpr1a |
bone morphogenetic protein receptor, type 1A |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:25741868 PMID:28492532 PMID:30093976 |
|
NCBI chr14:34,133,018...34,225,335
Ensembl chr14:34,132,691...34,225,298
|
|
G |
Palb2 |
partner and localizer of BRCA2 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 7:121,706,485...121,732,203
Ensembl chr 7:121,706,485...121,732,208
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Recql4 |
RecQ protein-like 4 |
|
ISO |
ClinVar Annotator: match by term: B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 |
ClinVar |
PMID:10678659 PMID:12734318 PMID:12838562 PMID:15964893 PMID:18716613 PMID:25741868 More...
|
|
NCBI chr15:76,587,753...76,594,820
Ensembl chr15:76,587,753...76,594,748
|
|
|
G |
Cbl |
Casitas B-lineage lymphoma |
|
ISO |
ClinVar Annotator: match by term: B lymphoblastic leukemia lymphoma with hyperdiploidy |
ClinVar |
PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346
|
|
|
G |
Sdha |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
|
ISO |
ClinVar Annotator: match by term: B-lymphoblastic leukemia/lymphoma with hypodiploidy |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr13:74,470,374...74,498,359
Ensembl chr13:74,470,373...74,498,399
|
|
|
G |
A4galt |
alpha 1,4-galactosyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11482875 |
|
NCBI chr15:83,110,923...83,135,930
Ensembl chr15:83,110,923...83,135,975
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080
|
|
G |
Bbc3 |
BCL2 binding component 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18573879 |
|
NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
|
|
G |
Bcl2l2 |
BCL2-like 2 |
|
ISO |
mRNA:increased expression:lymph node |
RGD |
PMID:28094768 |
RGD:14394511 |
NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691 Ensembl chr14:55,120,834...55,125,691
|
|
G |
Brca1 |
breast cancer 1, early onset |
|
ISO |
ClinVar Annotator: match by term: Burkitt lymphoma |
ClinVar |
PMID:17262179 PMID:26467025 PMID:28492532 PMID:31911673 |
|
NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
ameliorates treatment |
ISO |
Human cell line in a mouse model mRNA:increased expression:multiple (human) |
RGD |
PMID:28474336 PMID:30546948 |
RGD:124713565, RGD:124715474 |
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
|
|
G |
Calr |
calreticulin |
treatment |
ISO |
human cells and recombinant protein in a mouse model human cell line and recombinant protein in a mouse model |
RGD |
PMID:9858521 PMID:10961892 |
RGD:150521687, RGD:150521702 |
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
|
|
G |
Cct6b |
chaperonin containing TCP1 subunit 6B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr11:82,603,938...82,655,154
Ensembl chr11:82,610,076...82,655,147
|
|
G |
Cd40 |
CD40 antigen |
treatment |
ISO |
human cell line in a mouse model |
RGD |
PMID:9192773 |
RGD:11520790 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd79b |
CD79B antigen |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:17374736 |
RGD:151665154 |
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Ftcd |
formiminotransferase cyclodeaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr10:76,411,482...76,426,172
Ensembl chr10:76,411,482...76,426,172
|
|
G |
Gna13 |
guanine nucleotide binding protein, alpha 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr11:109,253,620...109,292,195
Ensembl chr11:109,253,657...109,292,195
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143595 PMID:23143597 |
|
NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066
|
|
G |
Mir21a |
microRNA 21a |
treatment |
ISO |
|
RGD |
PMID:27991481 |
RGD:41404643 |
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
|
|
G |
Mir23b |
microRNA 23b |
treatment |
ISO |
|
RGD |
PMID:27991481 |
RGD:41404643 |
NCBI chr13:63,448,298...63,448,371
Ensembl chr13:63,448,298...63,448,371
|
|
G |
Mllt11 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31587870 |
|
NCBI chr 3:95,125,852...95,139,486
Ensembl chr 3:95,126,446...95,139,482
|
|
G |
Myc |
myelocytomatosis oncogene |
|
IAGP ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Burkitt lymphoma OMIM:113970 DNA:mutations:exons:multiple (human) |
CTD ClinVar MouseDO OMIM RGD |
PMID:8220424 PMID:25157968 PMID:27993330 PMID:8220424 PMID:8397370 |
RGD:1601453, RGD:10059619 |
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Pbx1 |
pre B cell leukemia homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1967982 PMID:17244677 |
|
NCBI chr 1:167,946,933...168,259,898
Ensembl chr 1:167,946,933...168,259,839
|
|
G |
Pcx |
pyruvate carboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
|
|
G |
Ret |
ret proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
|
|
G |
Sall3 |
spalt like transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr18:81,010,204...81,030,236
Ensembl chr18:81,009,591...81,029,986
|
|
G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143597 |
|
NCBI chr 9:21,527,377...21,615,526
Ensembl chr 9:21,527,465...21,615,526
|
|
G |
Tcf3 |
transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1967982 PMID:17244677 |
|
NCBI chr10:80,245,375...80,269,814
Ensembl chr10:80,245,348...80,269,481
|
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
ameliorates |
ISO |
|
RGD |
PMID:28552327 |
RGD:124715478 |
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
|
|
G |
Cd79b |
CD79B antigen |
treatment |
ISO |
|
RGD |
PMID:28619981 |
RGD:151665208 |
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
DNA:SNP:promoter:-1082G>A (human) |
RGD |
PMID:22628023 |
RGD:7364831 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
treatment |
ISO |
|
RGD |
PMID:28619981 |
RGD:151665208 |
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
|
G |
Ctcf |
CCCTC-binding factor |
disease_progression |
ISO |
mRNA, protein:increased expression:bone marrow, blood (human) |
RGD |
PMID:24393203 |
RGD:151356757 |
NCBI chr 8:106,351,135...106,409,554
Ensembl chr 8:106,363,200...106,409,554
|
|
|
G |
Ak3 |
adenylate kinase 3 |
|
ISO |
protein:increased expression:peripheral blood mononuclear cell |
RGD |
PMID:27078856 |
RGD:13842476 |
NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
|
|
G |
Braf |
Braf transforming gene |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12068308 PMID:12198537 PMID:12960123 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15035987 PMID:16187918 PMID:17096326 PMID:17119447 PMID:17311103 PMID:18368129 PMID:18794803 PMID:19206169 PMID:19383316 PMID:19537845 PMID:19913317 PMID:20350999 PMID:20619739 PMID:21129611 PMID:21639808 PMID:22048237 PMID:22310681 PMID:22495831 PMID:22663011 PMID:22972589 PMID:23352452 PMID:24033266 PMID:24451042 PMID:25157968 PMID:26619011 PMID:28492532 PMID:28832562 PMID:29595366 More...
|
|
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:9450802 |
RGD:11522717 |
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd79b |
CD79B antigen |
|
ISO |
protein:decreased expression:peripheral blood cells (human) mRNA, protein:splice variants, alternative forms:exon 3 (human) protein:decreased expression:blood, B cell (human) protein:decreased expression:blood cells (human) |
RGD |
PMID:10516749 PMID:10090943 PMID:10329919 PMID:10753858 |
RGD:151665125, RGD:151665190, RGD:11531139, RGD:151665152 |
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Cd86 |
CD86 antigen |
|
ISO |
DNA:hypermethylation (human) |
RGD |
PMID:23154584 |
RGD:11354975 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Fbxw7 |
F-box and WD-40 domain protein 7 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:25741868 PMID:26619011 |
|
NCBI chr 3:84,721,901...84,886,505
Ensembl chr 3:84,722,575...84,886,505
|
|
G |
Hras |
Harvey rat sarcoma virus oncogene |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:31775759 PMID:32732226 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21911837 |
RGD:11354912 |
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
|
|
G |
Irf4 |
interferon regulatory factor 4 |
disease_progression |
IMP ISO |
DNA:SNPs:3' utr:multiple DNA:SNP: :rs872071 (human) DNA:missense mutation:exon:p.L116R (human) |
RGD |
PMID:23897826 PMID:20123861 PMID:20731705 PMID:23926303 PMID:20090783 PMID:21791429 More...
|
RGD:11526156, RGD:11530031, RGD:11530029, RGD:11530026, RGD:11530021, RGD:11526158 |
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Kras |
Kirsten rat sarcoma viral oncogene homolog |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:2278970 PMID:3122217 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 More...
|
|
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12835555 PMID:16329078 PMID:16372351 PMID:16835863 PMID:17211612 PMID:17384584 PMID:18042262 PMID:19213030 PMID:19255327 PMID:19773371 PMID:20859122 PMID:21438134 PMID:21495179 PMID:21850009 PMID:22256804 PMID:22499344 PMID:22683711 PMID:22726224 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24224811 PMID:24390138 PMID:25157968 PMID:25326635 PMID:25741868 PMID:26619011 PMID:27283355 PMID:27444071 PMID:28492532 PMID:29493581 PMID:31775759 PMID:32732226 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 7:140,774,024...140,789,968
Ensembl chr 7:140,774,070...140,789,968
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:peripheral blood mononuclear cell |
RGD |
PMID:29658610 |
RGD:21081544 |
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
|
|
G |
Mir21a |
microRNA 21a |
|
ISO |
miRNA:increased expression:peripheral blood mononuclear cell |
RGD |
PMID:29658610 |
RGD:21081544 |
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
|
|
G |
Myc |
myelocytomatosis oncogene |
disease_progression |
ISO |
|
RGD |
PMID:20956327 |
RGD:11340590 |
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:26619011 PMID:28492532 More...
|
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Nras |
neuroblastoma ras oncogene |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 More...
|
|
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
|
|
G |
Pon1 |
paraoxonase 1 |
susceptibility |
ISO |
DNA:missense mutations:cds:p.L55M, p.Q192R (human) |
RGD |
PMID:26254371 |
RGD:11073982 |
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:12717436 PMID:14644997 PMID:15385933 PMID:15710330 PMID:15928039 PMID:16358218 PMID:17972951 PMID:19047918 PMID:19179468 PMID:24033266 PMID:25097206 PMID:25395418 PMID:25741868 PMID:26619011 PMID:27069254 PMID:28098151 PMID:30868567 More...
|
|
NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
susceptibility |
ISO |
DNA:snp:cds:p.R620W (rs2476601) (human) protein:increased expression:B cell (human) |
RGD |
PMID:23287625 PMID:22569400 |
RGD:11533998, RGD:11535006 |
NCBI chr 3:103,763,891...103,819,568
Ensembl chr 3:103,767,111...103,819,563
|
|
G |
Sf3b1 |
splicing factor 3b, subunit 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:26619011 |
|
NCBI chr 1:55,024,328...55,066,660
Ensembl chr 1:55,024,328...55,066,640
|
|
G |
Sf3b2 |
splicing factor 3b, subunit 2 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:26619011 |
|
NCBI chr19:5,323,949...5,345,485
Ensembl chr19:5,323,960...5,345,483
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
protein:increased phosphorylation:peripheral blood mononuclear cell |
RGD |
PMID:29658610 |
RGD:21081544 |
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Trp53 |
transformation related protein 53 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:1359493 PMID:1565143 PMID:1565144 PMID:1631137 PMID:1679237 PMID:1683921 PMID:1978757 PMID:2046748 PMID:2531845 PMID:2554494 PMID:7651740 PMID:7732013 PMID:7737263 PMID:7791795 PMID:7887414 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8423216 PMID:8425176 PMID:8479749 PMID:8527048 PMID:8718514 PMID:8825920 PMID:9150393 PMID:9242456 PMID:9290701 PMID:9364015 PMID:9407971 PMID:9546439 PMID:9569050 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9825943 PMID:9839505 PMID:10064694 PMID:10089074 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10589545 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10922393 PMID:11051239 PMID:11139324 PMID:11180592 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11593407 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12406399 PMID:12506399 PMID:12672316 PMID:12700230 PMID:12726864 PMID:12826609 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15381368 PMID:15390294 PMID:15607980 PMID:15607981 PMID:15722483 PMID:15825182 PMID:15925506 PMID:15951970 PMID:15977174 PMID:16337994 PMID:16401470 PMID:16489069 PMID:16682957 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17308077 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17540308 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17881637 PMID:18307025 PMID:18511570 PMID:18685109 PMID:18937320 PMID:19101993 PMID:19147582 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19556618 PMID:19681600 PMID:19850740 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20128691 PMID:20308654 PMID:20407015 PMID:20505364 PMID:20516128 PMID:20522432 PMID:20693561 PMID:20805372 PMID:20878954 PMID:21056685 PMID:21059199 PMID:21115975 PMID:21159183 PMID:21187651 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21761402 PMID:22006311 PMID:22110706 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22484423 PMID:22713868 PMID:22811390 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23263379 PMID:23265383 PMID:23484829 PMID:23538418 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24381225 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24744791 PMID:24810334 PMID:25157968 PMID:25293557 PMID:25294809 PMID:25339994 PMID:25503501 PMID:25504633 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:26014290 PMID:26024390 PMID:26230955 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26534844 PMID:26585234 PMID:26619011 PMID:26681312 PMID:26781615 PMID:26787237 PMID:26822237 PMID:26845104 PMID:27179933 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27493922 PMID:27501770 PMID:27523101 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27873457 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28152038 PMID:28160093 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28873162 PMID:29025599 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29752822 PMID:29979965 PMID:30076369 PMID:30216591 PMID:30224644 PMID:30322717 PMID:30327374 PMID:30583724 PMID:30630526 PMID:30816478 PMID:30840781 PMID:31105275 PMID:31119730 PMID:31127191 PMID:31300551 PMID:31748977 PMID:31775759 PMID:31882575 PMID:32000721 PMID:32187361 PMID:32295079 PMID:32817165 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33372952 PMID:33471991 PMID:34026625 PMID:34308366 PMID:34994652 PMID:36988593 More...
|
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Xpo1 |
exportin 1 |
|
ISO |
ClinVar Annotator: match by term: Chronic lymphatic leukemia |
ClinVar |
PMID:26619011 |
|
NCBI chr11:23,205,768...23,248,250
Ensembl chr11:23,206,041...23,248,249
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21325069 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625222 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Alk |
anaplastic lymphoma kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chr17:72,174,206...72,911,719
Ensembl chr17:72,175,967...72,911,622
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7688627 |
|
NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
|
|
G |
Bcas2 |
BCAS2 pre-mRNA processing factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
NCBI chr 3:103,078,971...103,086,479
Ensembl chr 3:103,078,971...103,086,482
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l2 |
BCL2-like 2 |
disease_progression |
ISO |
|
RGD |
PMID:28094768 |
RGD:14394511 |
NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691 Ensembl chr14:55,120,834...55,125,691
|
|
G |
Bcl6 |
B cell leukemia/lymphoma 6 |
disease_progression |
ISO |
diffuse large B-cell lymphoma |
RGD |
PMID:11821949 PMID:15701085 |
RGD:1600111, RGD:11530023 |
NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:24869598 PMID:25082755 PMID:25189416 PMID:25741868 PMID:27199251 PMID:28049639 PMID:28212557 PMID:28418267 PMID:28492532 PMID:29496671 PMID:29875397 PMID:30018078 PMID:32455989 PMID:33154951 PMID:36029036 More...
|
|
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
|
ISO |
DNA:missense mutations:exons:multiple (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25049379 PMID:26192916 PMID:18323416 |
RGD:11100036 |
NCBI chr 5:140,858,754...140,986,351
Ensembl chr 5:140,858,745...140,986,337
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23828858 |
|
NCBI chr19:10,918,845...10,926,630
Ensembl chr19:10,918,845...10,926,630
|
|
G |
Cd22 |
CD22 antigen |
treatment |
ISO |
|
RGD |
PMID:25708834 |
RGD:151665133 |
NCBI chr 7:30,564,829...30,579,767
Ensembl chr 7:30,564,827...30,579,767
|
|
G |
Cd40 |
CD40 antigen |
susceptibility |
ISO |
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) |
RGD |
PMID:20473910 |
RGD:5490541 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd79a |
CD79A antigen (immunoglobulin-associated alpha) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25049379 |
|
NCBI chr 7:24,596,922...24,601,283
Ensembl chr 7:24,596,806...24,601,622
|
|
G |
Cd79b |
CD79B antigen |
severity treatment |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Diffuse large B cell lymphoma DNA:missense mutation:multiple, exon 5 (human) DNA:missense mutation:multiple, exon 5-6 (human) DNA:mutation:multiple (human) |
CTD ClinVar RGD |
PMID:11160144 PMID:21173233 PMID:31402495 PMID:31609782 PMID:25347427 PMID:25708834 PMID:28803429 More...
|
RGD:151665203, RGD:11075852, RGD:151665133, RGD:151665120 |
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19223503 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21325069 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Cltc |
clathrin heavy chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chr11:86,585,178...86,648,637
Ensembl chr11:86,585,177...86,648,391
|
|
G |
Dicer1 |
dicer 1, ribonuclease type III |
disease_progression |
ISO |
|
RGD |
PMID:25195038 |
RGD:149735347 |
NCBI chr12:104,654,001...104,718,331
Ensembl chr12:104,654,001...104,718,211
|
|
G |
Etv6 |
ets variant 6 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:35053500 |
|
NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20081860 PMID:28438623 |
RGD:126779596 |
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26192916 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fcgr3 |
Fc receptor, IgG, low affinity III |
disease_progression |
ISO |
DNA:SNP: :rs1801274 (human) |
RGD |
PMID:27282998 |
RGD:11344967 |
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
|
|
G |
Foxo1 |
forkhead box O1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:26314988 PMID:29721381 PMID:35079069 |
|
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
|
|
G |
Gli1 |
GLI-Kruppel family member GLI1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625222 |
|
NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
treatment |
ISO |
|
RGD |
PMID:20303013 |
RGD:10450835 |
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
susceptibility |
ISO |
DNA:SNP: :(rs1695)(human) |
RGD |
PMID:19338043 |
RGD:8547939 |
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
severity |
ISO |
DNA:deletion:cds: |
RGD |
PMID:20303013 |
RGD:10450835 |
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
disease_progression |
ISO |
proteion:increased expression:serum: |
RGD |
PMID:12598355 |
RGD:11354982 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
diffuse large B-cell lymphoma |
RGD |
PMID:11821949 |
RGD:1600111 |
NCBI chr 7:125,202,424...125,232,742
Ensembl chr 7:125,202,601...125,232,742
|
|
G |
Immp2l |
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
NCBI chr12:41,074,060...42,002,371
Ensembl chr12:41,074,089...42,002,371
|
|
G |
Irf4 |
interferon regulatory factor 4 |
disease_progression |
ISO |
|
RGD |
PMID:15701085 |
RGD:11530023 |
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21804550 |
|
NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085
|
|
G |
Malt1 |
MALT1 paracaspase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chr18:65,564,010...65,611,959
Ensembl chr18:65,564,009...65,612,138
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
disease_progression |
ISO |
|
RGD |
PMID:20919850 |
RGD:6483541 |
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:transition, transversion, haplotype:cds:g.677C>T, g.1298A>C (human) |
RGD |
PMID:17712558 |
RGD:6893517 |
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
|
|
G |
Myc |
myelocytomatosis oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Diffuse large B cell lymphoma DNA:missense mutation:L265P (human) DNA:mutation:L265P, L265S (human) |
CTD ClinVar RGD |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:25049379 PMID:26619011 PMID:28492532 PMID:31609782 PMID:25347427 PMID:28803429 More...
|
RGD:151665203, RGD:11075852, RGD:151665120 |
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Nectin2 |
nectin cell adhesion molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27356265 |
|
NCBI chr 7:19,450,569...19,483,498
Ensembl chr 7:19,450,569...19,484,408
|
|
G |
Nf1 |
neurofibromin 1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:21390130 PMID:22158541 PMID:23292937 |
|
NCBI chr11:79,223,541...79,472,435
Ensembl chr11:79,230,519...79,472,438
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
no_association |
ISO |
|
RGD |
PMID:15198731 |
RGD:2298905 |
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nom1 |
nucleolar protein with MIF4G domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chr 5:29,637,338...29,658,504
Ensembl chr 5:29,639,662...29,662,841
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chr17:24,292,654...24,370,957
Ensembl chr17:24,292,654...24,369,898
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21173233 |
|
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
|
|
G |
Prdm1 |
PR domain containing 1, with ZNF domain |
disease_progression |
ISO |
|
RGD |
PMID:22321048 |
RGD:150530470 |
NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
|
|
G |
Prdx3 |
peroxiredoxin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chr19:60,852,504...60,862,976
Ensembl chr19:60,852,489...60,862,994
|
|
G |
Prdx4 |
peroxiredoxin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chr X:154,106,914...154,125,268
Ensembl chr X:154,106,914...154,123,750
|
|
G |
Prmt5 |
protein arginine N-methyltransferase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31123343 |
|
NCBI chr14:54,744,639...54,754,927
Ensembl chr14:54,744,644...54,754,982
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27150054 |
|
NCBI chr15:81,588,449...81,614,120
Ensembl chr15:81,588,449...81,629,731
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19223503 |
|
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
|
|
G |
Sec31a |
SEC31 homolog A, COPII coat complex component |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22474449 |
|
NCBI chr 5:100,509,508...100,564,132
Ensembl chr 5:100,509,508...100,564,093
|
|
G |
Skp2 |
S-phase kinase-associated protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18850583 |
|
NCBI chr15:9,112,070...9,155,512
Ensembl chr15:9,112,073...9,155,512
|
|
G |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
|
IAGP |
|
MouseDO |
|
|
NCBI chr11:106,710,887...106,811,544
Ensembl chr11:106,710,892...106,811,541
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Sod3 |
superoxide dismutase 3, extracellular |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
|
|
G |
Syk |
spleen tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33782605 |
|
NCBI chr13:52,736,670...52,802,828
Ensembl chr13:52,737,209...52,802,828
|
|
G |
Tbl1xr1 |
transducin (beta)-like 1X-linked receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
ClinVar |
PMID:9450851 PMID:16492805 PMID:21156281 PMID:21156282 PMID:25741868 PMID:26769062 PMID:28562391 PMID:32619424 PMID:32932517 PMID:35165208 More...
|
|
NCBI chr 3:22,130,756...22,270,758
Ensembl chr 3:22,130,816...22,270,758
|
|
G |
Trp53 |
transformation related protein 53 |
|
IAGP ISO |
ClinVar Annotator: match by term: Diffuse large B cell lymphoma |
MouseDO ClinVar |
PMID:1631137 PMID:1978757 PMID:8062826 PMID:8099841 PMID:8425176 PMID:8527048 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:11051239 PMID:11782540 PMID:12826609 PMID:14743206 PMID:16489069 PMID:16818505 PMID:17417627 PMID:17427234 PMID:17606709 PMID:17881637 PMID:19378321 PMID:20013323 PMID:20128691 PMID:20407015 PMID:20522432 PMID:21059199 PMID:21343334 PMID:21519010 PMID:21601526 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26787237 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28472496 PMID:28492532 PMID:28724667 PMID:29025599 PMID:29979965 PMID:30224644 PMID:30327374 PMID:31127191 PMID:31775759 PMID:32187361 PMID:36988593 More...
|
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Txnip |
thioredoxin interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16081686 |
|
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
|
|
|
G |
Setd2 |
SET domain containing 2 |
|
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:27600764 |
RGD:150429643 |
NCBI chr 9:110,361,368...110,447,703
Ensembl chr 9:110,361,665...110,447,701
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29200404 |
|
NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550
|
|
|
G |
Bcl10 |
B cell leukemia/lymphoma 10 |
|
ISO |
ClinVar Annotator: match by term: MALT lymphoma |
ClinVar OMIM |
PMID:9989495 PMID:10380920 PMID:10408400 |
|
NCBI chr 3:145,630,017...145,640,121
Ensembl chr 3:145,628,559...145,640,111
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
treatment |
ISO |
DNA:gene fusion: (human) |
RGD |
PMID:21465313 |
RGD:153305955 |
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
protein:increased expression: mucosa-associated lymphoid tissue (human) |
RGD |
PMID:27544389 |
RGD:152023632 |
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
|
|
G |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
treatment |
ISO |
associated with Helicobacter Infections; DNA:polymorphim, haplotype: :HLA-DQA1*0103 (human) |
RGD |
PMID:16234023 |
RGD:5147794 |
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
|
|
|
G |
Atp6ap1 |
ATPase, H+ transporting, lysosomal accessory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26691987 |
|
NCBI chr X:73,340,703...73,348,327
Ensembl chr X:73,340,703...73,348,327
|
|
G |
Atp6v1b2 |
ATPase, H+ transporting, lysosomal V1 subunit B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26691987 |
|
NCBI chr 8:69,541,388...69,566,370
Ensembl chr 8:69,541,298...69,566,363
|
|
G |
Bcl10 |
B cell leukemia/lymphoma 10 |
|
ISO |
ClinVar Annotator: match by term: Follicular lymphoma |
ClinVar |
PMID:9989495 |
|
NCBI chr 3:145,630,017...145,640,121
Ensembl chr 3:145,628,559...145,640,111
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
susceptibility |
ISO |
DNA:translocation: ;t(14;18)(q32;q21) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:3287162 PMID:12855623 PMID:16671111 PMID:3287162 |
RGD:1599473, RGD:734639 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Cd40 |
CD40 antigen |
susceptibility |
ISO |
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) |
RGD |
PMID:20473910 |
RGD:5490541 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
human gene in a mouse model |
RGD |
PMID:25582824 |
RGD:11344981 |
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd79b |
CD79B antigen |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:17374736 |
RGD:151665154 |
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
|
|
G |
Ebf1 |
early B cell factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chr11:44,502,738...44,898,923
Ensembl chr11:44,508,144...44,898,918
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
Irf4 |
interferon regulatory factor 4 |
severity |
ISO |
|
RGD |
PMID:17296585 |
RGD:11530032 |
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Kdsr |
3-ketodihydrosphingosine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25526675 PMID:8417785 |
RGD:1598985 |
NCBI chr 1:106,648,140...106,689,544
Ensembl chr 1:106,648,189...106,687,457
|
|
G |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16410450 |
|
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16410450 |
|
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Rarres1 |
retinoic acid receptor responder (tazarotene induced) 1 |
|
IAGP |
OMIM:151430 |
MouseDO |
|
|
NCBI chr 3:67,386,219...67,422,856
Ensembl chr 3:67,386,305...67,422,856
|
|
G |
Rragc |
Ras-related GTP binding C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26691987 |
|
NCBI chr 4:123,811,226...123,830,790
Ensembl chr 4:123,811,239...123,830,790
|
|
G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24362818 |
|
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
|
|
G |
Tyms |
thymidylate synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16410450 |
|
NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
|
|
|
G |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
disease_progression |
ISO |
|
RGD |
PMID:26722499 |
RGD:11553660 |
NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085
|
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
|
RGD |
PMID:8843970 |
RGD:11353776 |
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
|
RGD |
PMID:9613675 |
RGD:11522762 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241536 |
|
NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913
|
|
G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9058727 |
|
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
|
|
|
G |
Cd40 |
CD40 antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7621881 |
|
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7621881 PMID:8656679 |
|
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd68 |
CD68 antigen |
severity |
ISO |
associated with Epstein-Barr Virus Infections;protein:increased expression:tumor(human) protein:increased expression:tumor (human) |
RGD |
PMID:21071500 PMID:23045593 |
RGD:40925944, RGD:40925946 |
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17659339 |
|
NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17562247 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma |
ClinVar |
PMID:28492532 PMID:32934698 |
|
NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma |
ClinVar |
PMID:32934698 |
|
NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21037568 |
|
NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
disease_progression |
ISO |
|
RGD |
PMID:21916526 |
RGD:10450802 |
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11406608 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
disease_progression |
ISO |
|
RGD |
PMID:21916526 |
RGD:10450802 |
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:serum: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7621881 PMID:8656679 PMID:7686390 |
RGD:11520780 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:21466366 |
RGD:11049168 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO |
DNA:SNPs: :multiple |
RGD |
PMID:19573080 PMID:21466366 |
RGD:11049165, RGD:11049168 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Jun |
jun proto-oncogene |
|
ISO |
|
RGD |
PMID:12145210 |
RGD:1549449 |
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Junb |
jun B proto-oncogene |
|
ISO |
|
RGD |
PMID:12145210 |
RGD:1549449 |
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
|
|
G |
Klhdc8b |
kelch domain containing 8B |
susceptibility |
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:19706467 |
|
NCBI chr 9:108,324,834...108,338,780
Ensembl chr 9:108,324,835...108,338,780
|
|
G |
Kras |
Kirsten rat sarcoma viral oncogene homolog |
|
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma |
ClinVar |
PMID:16361624 PMID:16618717 PMID:18316791 PMID:19114683 PMID:19679400 PMID:20147967 PMID:20570890 PMID:20921462 PMID:20921465 PMID:21228335 PMID:21398618 PMID:25157968 PMID:25251940 PMID:26110767 PMID:26970110 PMID:28492532 PMID:30289595 PMID:30891959 PMID:32934698 More...
|
|
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7545087 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Met |
met proto-oncogene |
|
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma |
ClinVar |
PMID:1104268 PMID:14559814 PMID:17483355 PMID:21970370 PMID:22703879 PMID:23806086 PMID:24088041 PMID:24728327 PMID:25605252 PMID:25736269 PMID:25741868 PMID:25859546 PMID:26467025 PMID:28492532 PMID:32934698 More...
|
|
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24688052 |
|
NCBI chr 6:83,282,686...83,302,926
Ensembl chr 6:83,282,673...83,302,890
|
|
G |
Myc |
myelocytomatosis oncogene |
|
ISO |
ClinVar Annotator: match by term: Classic Hodgkin lymphoma |
ClinVar |
PMID:32934698 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19223558 PMID:10556199 PMID:10340377 |
RGD:2298894, RGD:2298893 |
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Pramex1 |
PRAME like, X-linked 1 |
severity |
ISO |
mRNA:increased expression:lymphoid tissue (human) |
RGD |
PMID:26044287 |
RGD:11060455 |
NCBI chr X:134,513,662...134,528,437
Ensembl chr X:134,513,751...134,528,454
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24531327 |
|
NCBI chr 2:167,772,670...167,821,305
Ensembl chr 2:167,773,977...167,821,305
|
|
G |
Pvt1 |
Pvt1 oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21037568 |
|
NCBI chr15:61,909,835...62,132,064
Ensembl chr15:61,909,817...62,249,945
|
|
G |
Rel |
reticuloendotheliosis oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21037568 |
|
NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970
|
|
G |
Sdc1 |
syndecan 1 |
|
ISO |
protein:altered expression:tumor (human) |
RGD |
PMID:9746758 |
RGD:9743928 |
NCBI chr12:8,821,396...8,843,716
Ensembl chr12:8,821,323...8,843,715
|
|
G |
Tnfrsf8 |
tumor necrosis factor receptor superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7621881 PMID:8701986 PMID:10908157 PMID:12358914 PMID:12453859 PMID:16879607 PMID:17261581 More...
|
|
NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734
|
|
G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7621881 PMID:8656679 PMID:8701986 PMID:8896393 PMID:9058727 PMID:10908157 PMID:11552987 PMID:12358914 More...
|
|
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18768784 |
|
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
|
|
|
G |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
|
ISO |
|
OMIM |
|
|
NCBI chr 2:168,318,330...168,443,900
Ensembl chr 2:168,318,330...168,443,577
|
|
|
G |
Foxo1 |
forkhead box O1 |
|
IMP |
|
RGD |
PMID:17254969 |
RGD:155630604 |
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
|
|
G |
Foxo3 |
forkhead box O3 |
|
IMP |
|
RGD |
PMID:17254969 |
RGD:155630604 |
NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
|
|
G |
Foxo4 |
forkhead box O4 |
|
IMP |
|
RGD |
PMID:17254969 |
RGD:155630604 |
NCBI chr X:100,297,855...100,304,479
Ensembl chr X:100,298,134...100,304,479
|
|
|
G |
Aicda |
activation-induced cytidine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23589568 |
|
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
|
|
G |
Bcl2l1 |
BCL2-like 1 |
|
ISO |
|
RGD |
PMID:21998213 |
RGD:11353857 |
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
|
IDA |
DNA:hypermethylation:promoter: |
RGD |
PMID:10602427 |
RGD:11252194 |
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
|
|
G |
Clptm1l |
CLPTM1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24292274 |
|
NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724
|
|
G |
Eng |
endoglin |
disease_progression |
ISO |
|
RGD |
PMID:25030442 |
RGD:11041170 |
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
|
|
G |
Etv6 |
ets variant 6 |
|
ISO |
DNA:translocation: : |
RGD |
PMID:9539781 |
RGD:10450724 |
NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
|
|
G |
Fcgr2b |
Fc receptor, IgG, low affinity IIb |
treatment |
ISO |
|
RGD |
PMID:20705761 |
RGD:11344969 |
NCBI chr 1:170,786,186...170,804,141
Ensembl chr 1:170,786,186...170,804,116
|
|
G |
Fcgr3 |
Fc receptor, IgG, low affinity III |
no_association treatment |
ISO |
DNA:polymorphism:exon:p.H131A (human) |
RGD |
PMID:15217834 PMID:20705761 |
RGD:11344968, RGD:11344969 |
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
|
|
G |
Fcgr4 |
Fc receptor, IgG, low affinity IV |
no_association |
ISO |
DNA:polymorphism:exon:p.F158V (rs396991) (human) |
RGD |
PMID:15217834 |
RGD:11344968 |
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
|
|
G |
Gsr |
glutathione reductase |
|
ISO |
protein:increased activity:erythrocyte: |
RGD |
PMID:8569275 |
RGD:11059504 |
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
susceptibility |
ISO |
|
RGD |
PMID:22537952 |
RGD:10450797 |
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
susceptibility |
ISO |
DNA:polymorphism:cds:p.I105V(human) |
RGD |
PMID:12010828 |
RGD:10755404 |
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
susceptibility |
ISO |
|
RGD |
PMID:22537952 |
RGD:10450797 |
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24292274 |
|
NCBI chr10:6,835,779...6,973,185
Ensembl chr10:6,835,796...7,002,478
|
|
G |
Kmt2a |
lysine (K)-specific methyltransferase 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17463288 |
|
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
|
|
G |
Lyl1 |
lymphoblastomic leukemia 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3162254 |
|
NCBI chr 8:85,428,051...85,432,876
Ensembl chr 8:85,428,078...85,431,569
|
|
G |
Mecom |
MDS1 and EVI1 complex locus |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23770046 |
|
NCBI chr 3:30,005,445...30,563,937
Ensembl chr 3:30,005,445...30,602,157
|
|
G |
Pot1a |
protection of telomeres 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23502782 PMID:24292274 |
|
NCBI chr 6:25,743,939...25,809,280
Ensembl chr 6:25,743,736...25,809,245
|
|
G |
Runx1 |
runt related transcription factor 1 |
|
ISO |
DNA:translocation: : |
RGD |
PMID:9539781 |
RGD:10450724 |
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24292274 |
|
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
|
G |
Aicda |
activation-induced cytidine deaminase |
disease_progression |
ISO |
|
RGD |
PMID:18090274 |
RGD:32716407 |
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7680712 PMID:9817281 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12176798 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Sdc1 |
syndecan 1 |
|
ISO |
protein:altered expression:tumor (human) |
RGD |
PMID:11157493 |
RGD:9743929 |
NCBI chr12:8,821,396...8,843,716
Ensembl chr12:8,821,323...8,843,715
|
|
G |
Tfrc |
transferrin receptor |
treatment |
ISO |
|
RGD |
PMID:26325374 |
RGD:11062098 |
NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612
|
|
|
|